AutismKB 2.0

Annotation Detail for EGF


View Evidences View Variants View Annotations
Basic Information Top
Gene Symbol:EGF ( HOMG4,URG )
Gene Full Name: epidermal growth factor
Band: 4q25
Quick LinksEntrez ID:1950; OMIM: 131530; Uniprot ID:EGF_HUMAN; ENSEMBL ID: ENSG00000138798; HGNC ID: 3229
Relate to Another Database: SFARIGene; denovo-db
Related Pathway Information Top
No data
Pathway IDPathway Name
hsa05160Hepatitis C
hsa04012ErbB signaling pathway
hsa04010MAPK signaling pathway
hsa04144Endocytosis
hsa04540Gap junction
hsa05219Bladder cancer
hsa05223Non-small cell lung cancer
hsa04810Regulation of actin cytoskeleton
hsa05218Melanoma
hsa05212Pancreatic cancer
hsa05213Endometrial cancer
hsa05214Glioma
hsa05215Prostate cancer
hsa04510Focal adhesion
hsa04060Cytokine-cytokine receptor interaction
hsa05200Pathways in cancer
Pathway IDPathway Name
Hemostasis
Signaling by EGFR
Pathway IDPathway Name
200033Signaling events mediated by PTP1B
200136ErbB receptor signaling network
200155Stabilization and expansion of the E-cadherin adherens junction
200146Internalization of ErbB1
200085EGF receptor (ErbB1) signaling pathway
200069Thromboxane A2 receptor signaling
200060Arf6 signaling events
200065Signaling events mediated by TCPTP
200095EGFR-dependent Endothelin signaling events
200072Regulation of Telomerase
200162a6b1 and a6b4 Integrin signaling
200113ErbB1 downstream signaling
200100Ceramide signaling pathway
No data
Pathway IDPathway Name
500510Signaling by EGFR
500515EGFR downregulation
Related Diseases/Disorders Top
Desease IDDesease Name
Cancers
Cancers of the digestive system
H00018Gastric cancer
Desease IDDesease Name
1731Growth retardation
1763Keratosis
1774Necrotizing enterocolitis
1781Rheumatoid arthritis
1870Drug abuse
1901Endometriosis
1902Kidney failure
1904Diabetes mellitus
1934Cancer
2052Infection
2069Schizophrenia
2083IGA glomerulonephritis
2124Autistic disorder
2233Cirrhosis
2248Cytomegalovirus infection
Desease Name
periodontitis
CARDIOVASCULAR
Birth Weight
prostate cancer
brain cancer
CANCER
PSYCH
stomach cancer
IMMUNE
schizophrenia
METABOLIC
arrhythmia, cardiac
heart rate
DEVELOPMENTAL
malignant melanoma
hair morphology
Desease Name
Hair morphology
Desease Name
Hypomagnesemia 4, renal
Comparative Toxicogenomics Database Top
Chemical ID Chemical Name Interaction Interaction Action Publication
C070379 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [EGF protein affects the localization of PRKCB protein]affects localization|decreases reaction 17991733
C025984 15-hydroxy-5,8,11,13-eicosatetraenoic acid 15-hydroxy-5,8,11,13-eicosatetraenoic acid promotes the reaction [EGF protein affects the localization of PRKCA protein]affects localization|increases reaction 15613483
C025984 15-hydroxy-5,8,11,13-eicosatetraenoic acid EGF protein results in increased chemical synthesis of 15-hydroxy-5,8,11,13-eicosatetraenoic acidincreases chemical synthesis 15613483
C023013 17 alpha-iodoethynylestradiol [EGF protein co-treated with 17 alpha-iodoethynylestradiol] results in increased expression of MYC mRNAaffects cotreatment|increases expression 12632255
C016403 2,4-dinitrotoluene 2,4-dinitrotoluene affects the expression of EGF mRNAaffects expression 21346803
C085911 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [EGF protein results in increased phosphorylation of RPS6KB1 protein]decreases reaction|increases phosphorylation 11959800
C085911 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [EGF protein results in decreased expression of and results in decreased secretion of KLK3 protein]decreases expression|decreases reaction|decreases secretion 16472761
C085911 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [EGF protein results in decreased expression of AR protein]decreases expression|decreases reaction 16472761
C085911 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [EGF protein results in increased expression of AQP3 protein]decreases reaction|increases expression 16848764
18214481
C085911 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein]decreases reaction|increases phosphorylation 16472761
16619521
16343977
C023514 2,6-dinitrotoluene 2,6-dinitrotoluene affects the expression of EGF mRNAaffects expression 21346803
C088860 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [EGF protein affects the localization of PRKCA protein]affects localization|decreases reaction 15613483
C088860 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [EGF protein results in increased expression of AQP3 protein]decreases reaction|increases expression 16848764
18214481
C009505 4,4'-diaminodiphenylmethane 4,4'-diaminodiphenylmethane results in decreased expression of EGF mRNAdecreases expression 18648102
C009505 4,4'-diaminodiphenylmethane 4,4'-diaminodiphenylmethane results in decreased expression of EGF mRNAdecreases expression 18289764
C098874 4,5-dianilinophthalimide 4,5-dianilinophthalimide inhibits the reaction [EGF protein results in increased susceptibility to Desoxycorticosterone]decreases reaction|increases response to substance 11751714
C108123 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein]decreases reaction|increases phosphorylation 15849355
C016601 4-hydroxytamoxifen [4-hydroxytamoxifen co-treated with EGF protein] results in increased expression of CDH1 mRNAaffects cotreatment|increases expression 19593637
C016601 4-hydroxytamoxifen [4-hydroxytamoxifen co-treated with EGF protein] results in increased expression of CDH1 proteinaffects cotreatment|increases expression 19593637
C016601 4-hydroxytamoxifen AG 1879 inhibits the reaction [[4-hydroxytamoxifen co-treated with EGF protein] results in increased expression of CDH1 protein]affects cotreatment|decreases reaction|increases expression 19593637
C016601 4-hydroxytamoxifen fulvestrant inhibits the reaction [[4-hydroxytamoxifen co-treated with EGF protein] results in increased expression of CDH1 protein]affects cotreatment|decreases reaction|increases expression 19593637
C016601 4-hydroxytamoxifen PD 98059 inhibits the reaction [[4-hydroxytamoxifen co-treated with EGF protein] results in increased expression of CDH1 protein]affects cotreatment|decreases reaction|increases expression 19593637
C059539 4'-N-benzoylstaurosporine 4'-N-benzoylstaurosporine inhibits the reaction [EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of TP53 protein]]decreases reaction|increases activity|increases localization|increases phosphorylation 15542774
C105260 4-tert-octylphenol 4-tert-octylphenol results in increased expression of EGF mRNAincreases expression 17011747
C046215 8-hydroxyguanosine Acetylcysteine inhibits the reaction [EGF protein results in increased abundance of 8-hydroxyguanosine]decreases reaction|increases abundance 11158190
C046215 8-hydroxyguanosine EGF protein results in increased abundance of 8-hydroxyguanosineincreases abundance 11158190
C046215 8-hydroxyguanosine Selenium inhibits the reaction [EGF protein results in increased abundance of 8-hydroxyguanosine]decreases reaction|increases abundance 11158190
D000079 Acetaldehyde chelerythrine inhibits the reaction [EGF protein inhibits the reaction [Acetaldehyde affects the localization of TJP1 protein]]affects localization|decreases reaction 17991733
D000079 Acetaldehyde chelerythrine inhibits the reaction [EGF protein results in decreased susceptibility to Acetaldehyde]decreases reaction|decreases response to substance 17991733
D000079 Acetaldehyde EGF protein inhibits the reaction [Acetaldehyde affects the localization of OCLN protein]affects localization|decreases reaction 17991733
D000079 Acetaldehyde EGF protein inhibits the reaction [Acetaldehyde affects the localization of TJP1 protein]affects localization|decreases reaction 17991733
D000079 Acetaldehyde EGF protein inhibits the reaction [Acetaldehyde results in increased transport of Inulin]decreases reaction|increases transport 17991733
D000079 Acetaldehyde EGF protein results in decreased susceptibility to Acetaldehydedecreases response to substance 17991733
D000079 Acetaldehyde PLCG1 protein affects the reaction [EGF protein inhibits the reaction [Acetaldehyde affects the localization of OCLN protein]]affects localization|affects reaction|decreases reaction 17991733
D000079 Acetaldehyde PLCG1 protein affects the reaction [EGF protein inhibits the reaction [Acetaldehyde affects the localization of TJP1 protein]]affects localization|affects reaction|decreases reaction 17991733
D000079 Acetaldehyde PRKCB protein affects the reaction [EGF protein inhibits the reaction [Acetaldehyde results in increased transport of Inulin]]affects reaction|decreases reaction|increases transport 17991733
D000079 Acetaldehyde PRKCB protein affects the reaction [EGF protein results in decreased susceptibility to Acetaldehyde]affects reaction|decreases response to substance 17991733
D000079 Acetaldehyde PRKCE protein affects the reaction [EGF protein inhibits the reaction [Acetaldehyde results in increased transport of Inulin]]affects reaction|decreases reaction|increases transport 17991733
D000079 Acetaldehyde PRKCE protein affects the reaction [EGF protein results in decreased susceptibility to Acetaldehyde]affects reaction|decreases response to substance 17991733
D000079 Acetaldehyde Ro 32-0432 inhibits the reaction [EGF protein inhibits the reaction [Acetaldehyde affects the localization of TJP1 protein]]affects localization|decreases reaction 17991733
D000079 Acetaldehyde Ro 32-0432 inhibits the reaction [EGF protein results in decreased susceptibility to Acetaldehyde]decreases reaction|decreases response to substance 17991733
D000082 Acetaminophen [EGF protein co-treated with HGF protein] promotes the reaction [Acetaminophen results in decreased expression of CYP1A2 mRNA]affects cotreatment|decreases expression|increases reaction 12969438
D000111 Acetylcysteine Acetylcysteine inhibits the reaction [EGF protein results in increased abundance of 8-hydroxyguanosine]decreases reaction|increases abundance 11158190
D000111 Acetylcysteine Acetylcysteine inhibits the reaction [EGF protein results in increased abundance of Peroxides]decreases reaction|increases abundance 11158190
C109238 acyline acyline results in decreased expression of EGF mRNAdecreases expression 17510436
D016604 Aflatoxin B1 Aflatoxin B1 affects the expression of EGF proteinaffects expression 20106945
C412373 AG 1879 AG 1879 inhibits the reaction [[4-hydroxytamoxifen co-treated with EGF protein] results in increased expression of CDH1 protein]affects cotreatment|decreases reaction|increases expression 19593637
C412373 AG 1879 EGF protein inhibits the reaction [AG 1879 inhibits the reaction [Testosterone results in increased phosphorylation of CREB1 protein]]decreases reaction|increases phosphorylation 17272394
C412373 AG 1879 EGF protein inhibits the reaction [AG 1879 inhibits the reaction [Testosterone results in increased phosphorylation of MAPK1 protein]]decreases reaction|increases phosphorylation 17272394
C412373 AG 1879 EGF protein inhibits the reaction [AG 1879 inhibits the reaction [Testosterone results in increased phosphorylation of MAPK3 protein]]decreases reaction|increases phosphorylation 17272394
C523074 allylpyrocatechol allylpyrocatechol promotes the reaction [Indomethacin results in increased expression of EGF protein]increases expression|increases reaction 18431645
C040534 alpha-hexachlorocyclohexane [EGF protein co-treated with alpha-hexachlorocyclohexane] results in increased expression of MYC mRNAaffects cotreatment|increases expression 12632255
D000538 Aluminum Silicates Aluminum Silicates results in increased secretion of EGF proteinincreases secretion 16335828
D019856 Ethanolamine Ethanolamine results in increased activity of EGF proteinincreases activity 15802876
D000643 Ammonium Chloride Ammonium Chloride affects the expression of EGF mRNAaffects expression 16483693
D000643 Ammonium Chloride [EGF protein co-treated with Ammonium Chloride] results in increased expression of MYC mRNAaffects cotreatment|increases expression 12632255
D000677 Amsacrine [EGF protein results in decreased expression of TOP2A protein] which results in decreased susceptibility to Amsacrinedecreases expression|decreases response to substance 16969495
C432165 anthra(1,9-cd)pyrazol-6(2H)-one anthra(1,9-cd)pyrazol-6(2H)-one promotes the reaction [EGF protein results in increased expression of CDKN1A mRNA]increases expression|increases reaction 15961274
C006632 arsenic trioxide arsenic trioxide results in increased expression of EGF mRNAincreases expression 15073043
D017638 Asbestos, Crocidolite Asbestos, Crocidolite affects the expression of EGF mRNAaffects expression 17331233
D001414 Bacitracin Bacitracin results in decreased expression of EGF mRNAdecreases expression 18289764
C095105 bexarotene bexarotene results in increased expression of EGF mRNAincreases expression 16648578
C053541 bicalutamide bicalutamide inhibits the reaction [FOS protein results in increased expression of EGF mRNA]decreases reaction|increases expression 15466214
D020001 1-Butanol 1-Butanol inhibits the reaction [EGF protein binds to and results in increased degradation of EGFR protein]affects binding|decreases reaction|increases degradation 11134345
D020001 1-Butanol 1-Butanol inhibits the reaction [EGF protein binds to and results in increased localization of EGFR protein]affects binding|decreases reaction|increases localization 11134345
D020001 1-Butanol 1-Butanol inhibits the reaction [EGF protein results in increased abundance of Phosphatidic Acids]decreases reaction|increases abundance 11134345
D020001 1-Butanol 1-Butanol inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]decreases reaction|increases phosphorylation 11134345
D020001 1-Butanol 1-Butanol inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]decreases reaction|increases phosphorylation 11134345
D002118 Calcium EGF protein results in increased abundance of Calciumincreases abundance 11527950
D002118 Calcium tyrphostin AG 1478 inhibits the reaction [EGF protein results in increased abundance of Calcium]decreases reaction|increases abundance 11527950
D002118 Calcium [IGF2 protein co-treated with EGF protein] results in increased import of Calciumaffects cotreatment|increases import 2442157
D002118 Calcium Calcium affects the expression of EGF mRNAaffects expression 15913539
D002118 Calcium [Calcium co-treated with Calcitriol] affects the expression of EGF mRNAaffects cotreatment|affects expression 15913539
C058819 calphostin C calphostin C inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]decreases reaction|increases activity|increases phosphorylation 16877402
C058819 calphostin C calphostin C inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of MAPK3 protein]decreases reaction|increases activity|increases phosphorylation 16877402
D002251 Carbon Tetrachloride Carbon Tetrachloride results in increased expression of EGF mRNAincreases expression 16097045
17631135
D002251 Carbon Tetrachloride IL10 protein affects the reaction [Carbon Tetrachloride results in increased expression of EGF mRNA]affects reaction|increases expression 16097045
D002251 Carbon Tetrachloride IL10 protein affects the reaction [Carbon Tetrachloride results in increased expression of EGF protein]affects reaction|increases expression 16097045
C016299 chelerythrine chelerythrine inhibits the reaction [EGF protein inhibits the reaction [Acetaldehyde affects the localization of TJP1 protein]]affects localization|decreases reaction 17991733
C016299 chelerythrine chelerythrine inhibits the reaction [EGF protein results in decreased susceptibility to Acetaldehyde]decreases reaction|decreases response to substance 17991733
D003474 Curcumin Curcumin inhibits the reaction [EGF protein results in increased expression of AQP3 protein]decreases reaction|increases expression 18214481
D003474 Curcumin Curcumin inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein]decreases reaction|increases phosphorylation 18214481
D003474 Curcumin Curcumin inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]decreases reaction|increases phosphorylation 10851300
18214481
15129424
D003474 Curcumin Curcumin inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]decreases reaction|increases phosphorylation 18214481
D003474 Curcumin Curcumin inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]decreases reaction|increases phosphorylation 18214481
D003474 Curcumin Curcumin inhibits the reaction [EGF protein results in increased secretion of PTHLH protein]decreases reaction|increases secretion 15129424
D003474 Curcumin Curcumin results in decreased activity of EGF proteindecreases activity 15486348
D003474 Curcumin Curcumin inhibits the reaction [EGF protein results in decreased expression of PPARG mRNA]decreases expression|decreases reaction 17372590
D003474 Curcumin Curcumin inhibits the reaction [EGF protein results in decreased expression of PPARG protein]decreases expression|decreases reaction 17372590
D003474 Curcumin Curcumin results in decreased expression of EGFdecreases expression 18462866
D003513 Cycloheximide Cycloheximide promotes the reaction [[EGF protein co-treated with Estradiol] results in increased expression of FOS mRNA]affects cotreatment|increases expression|increases reaction 12632255
D016572 Cyclosporine Cyclosporine results in increased expression of EGF mRNAincreases expression 20106945
D017373 Cyproterone Acetate [EGF protein co-treated with Cyproterone Acetate] results in increased expression of MYC mRNAaffects cotreatment|increases expression 12632255
D003609 Dactinomycin Dactinomycin inhibits the reaction [[EGF protein co-treated with Estradiol] results in increased expression of FOS mRNA]affects cotreatment|decreases reaction|increases expression 12632255
D003634 DDT [EGF protein co-treated with DDT] results in increased expression of MYC mRNAaffects cotreatment|increases expression 12632255
D015230 Prostaglandin D2 [EGF protein co-treated with Prostaglandin D2] results in increased expression of MYC mRNAaffects cotreatment|increases expression 12632255
D003907 Dexamethasone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ARHGAP5 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D003907 Dexamethasone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CALML4 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D003907 Dexamethasone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CLEC3B mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D003907 Dexamethasone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of FAS mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D003907 Dexamethasone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of FGF7 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D003907 Dexamethasone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of FZD2 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D003907 Dexamethasone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of IIGP1 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D003907 Dexamethasone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of KLF5 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D003907 Dexamethasone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of MARCKS mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D003907 Dexamethasone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of PDGFRB mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D003907 Dexamethasone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of PLTP mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D003907 Dexamethasone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of TNFRSF11B mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D003907 Dexamethasone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ACSL1 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D003907 Dexamethasone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of GPAM mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D003907 Dexamethasone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of HK2 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D003907 Dexamethasone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of IRS2 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D003907 Dexamethasone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of MGST1 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D003907 Dexamethasone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ORM1 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D003907 Dexamethasone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ORM2 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D003907 Dexamethasone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ORM3 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D003907 Dexamethasone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of SCD1 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D003907 Dexamethasone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of SLC4A4 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D003907 Dexamethasone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of SREBF1 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D003907 Dexamethasone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of TEAD4 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D003907 Dexamethasone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of XDH mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D003907 Dexamethasone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of AHR mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D003907 Dexamethasone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CCL2 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D003907 Dexamethasone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CP mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D003907 Dexamethasone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CXCL12 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D003907 Dexamethasone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CXCL1 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D003907 Dexamethasone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CXCL5 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D003907 Dexamethasone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of EMP1 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D003907 Dexamethasone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of IFI47 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D003907 Dexamethasone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of IFNAR2 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D003907 Dexamethasone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of KLF4 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D003907 Dexamethasone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of TIMP1 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D003907 Dexamethasone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of WISP2 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D003907 Dexamethasone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ANGPTL4 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D003907 Dexamethasone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CDO1 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D003907 Dexamethasone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPA mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D003907 Dexamethasone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CELF2 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D003907 Dexamethasone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of DGAT1 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D003907 Dexamethasone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of DNAJB9 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D003907 Dexamethasone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ENPP2 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D003907 Dexamethasone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of EPHX2 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D003907 Dexamethasone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D003907 Dexamethasone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FGFR2 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D003907 Dexamethasone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of GADD45G mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D003907 Dexamethasone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of HP mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D003907 Dexamethasone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of IGFBP3 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D003907 Dexamethasone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of IGFBP5 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D003907 Dexamethasone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of MAPK4 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D003907 Dexamethasone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of NAMPT mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D003907 Dexamethasone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PLIN2 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D003907 Dexamethasone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D003907 Dexamethasone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PTP4A1 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D003907 Dexamethasone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of TOB1 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D003907 Dexamethasone Dexamethasone promotes the reaction [[EGF protein co-treated with Estradiol] results in increased expression of FOS mRNA]affects cotreatment|increases expression|increases reaction 12632255
D002945 Cisplatin Cisplatin results in decreased expression of EGF mRNAdecreases expression 18289764
D002945 Cisplatin Cisplatin results in decreased expression of EGF proteindecreases expression 15033597
D004052 Diethylnitrosamine Diethylnitrosamine results in decreased expression of EGF mRNAdecreases expression 19638242
D004054 Diethylstilbestrol Diethylstilbestrol results in increased expression of EGF mRNAincreases expression 15336711
D004054 Diethylstilbestrol Diethylstilbestrol results in increased expression of EGF mRNAincreases expression 17011747
D004054 Diethylstilbestrol [EGF protein co-treated with Diethylstilbestrol] results in increased expression of MYC mRNAaffects cotreatment|increases expression 12632255
C011612 diethyl sulfate diethyl sulfate inhibits the reaction [EGF protein results in increased activity of RPS6KB1 protein]decreases reaction|increases activity 12960407
C011612 diethyl sulfate diethyl sulfate inhibits the reaction [EGF protein results in increased phosphorylation of RPS6KB1 protein]decreases reaction|increases phosphorylation 12960407
D002117 Calcitriol [Calcium co-treated with Calcitriol] affects the expression of EGF mRNAaffects cotreatment|affects expression 15913539
D019813 1,2-Dimethylhydrazine 1,2-Dimethylhydrazine results in increased expression of EGF proteinincreases expression 2788074
D004128 Dimethylnitrosamine Dimethylnitrosamine results in increased expression of EGF mRNAincreases expression 17203207
D004317 Doxorubicin [EGF protein results in decreased expression of TOP2A protein] which results in decreased susceptibility to Doxorubicindecreases expression|decreases response to substance 16969495
C045651 epigallocatechin gallate epigallocatechin gallate inhibits the reaction [EGF protein binds to EGFR protein]affects binding|decreases reaction 17616711
C045651 epigallocatechin gallate epigallocatechin gallate inhibits the reaction [EGF protein promotes the reaction [EGFR protein binds to EGFR protein]]affects binding|decreases reaction|increases reaction 17616711
C045651 epigallocatechin gallate epigallocatechin gallate inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]decreases reaction|increases phosphorylation 17616711
D004958 Estradiol EGF protein inhibits the reaction [[Estradiol co-treated with EGFR protein] results in increased expression of SIAH2 mRNA]affects cotreatment|decreases reaction|increases expression 18629630
D004958 Estradiol EGF protein inhibits the reaction [[Estradiol co-treated with EGFR protein] results in increased expression of SIAH2 protein]affects cotreatment|decreases reaction|increases expression 18629630
D004958 Estradiol EGF protein promotes the reaction [Estradiol results in increased expression of OLFM4 mRNA]increases expression|increases reaction 21048224
D004958 Estradiol EGF protein promotes the reaction [Estradiol results in increased phosphorylation of EGFR protein]increases phosphorylation|increases reaction 20005069
D004958 Estradiol Estradiol affects the activity of EGF proteinaffects activity 19395996
D004958 Estradiol Estradiol inhibits the reaction [EGF protein results in increased expression of PLAUR protein]decreases reaction|increases expression 19395996
D004958 Estradiol Estradiol promotes the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]increases phosphorylation|increases reaction 16901965
D004958 Estradiol Estradiol promotes the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]increases phosphorylation|increases reaction 16901965
D004958 Estradiol ICI 164384 inhibits the reaction [EGF protein promotes the reaction [Estradiol results in increased expression of OLFM4 mRNA]]decreases reaction|increases expression|increases reaction 21048224
D004958 Estradiol Cycloheximide promotes the reaction [[EGF protein co-treated with Estradiol] results in increased expression of FOS mRNA]affects cotreatment|increases expression|increases reaction 12632255
D004958 Estradiol Dactinomycin inhibits the reaction [[EGF protein co-treated with Estradiol] results in increased expression of FOS mRNA]affects cotreatment|decreases reaction|increases expression 12632255
D004958 Estradiol Dexamethasone promotes the reaction [[EGF protein co-treated with Estradiol] results in increased expression of FOS mRNA]affects cotreatment|increases expression|increases reaction 12632255
D004958 Estradiol [EGF protein co-treated with Estradiol] results in increased expression of FOS mRNAaffects cotreatment|increases expression 12632255
D004958 Estradiol Estradiol promotes the reaction [EGF protein results in increased expression of MYC mRNA]increases expression|increases reaction 12632255
D004958 Estradiol INS1 protein promotes the reaction [[EGF protein co-treated with Estradiol] results in increased expression of FOS mRNA]affects cotreatment|increases expression|increases reaction 12632255
C017296 estrone sulfate EGF protein promotes the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]increases reaction|increases uptake 15238352
C017296 estrone sulfate N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [EGF protein promotes the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]]decreases reaction|increases reaction|increases uptake 15238352
C017296 estrone sulfate PTGS1 protein promotes the reaction [EGF protein promotes the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]]increases reaction|increases uptake 15238352
C017296 estrone sulfate SC 560 inhibits the reaction [EGF protein promotes the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]]decreases reaction|increases reaction|increases uptake 15238352
D008656 Mestranol [EGF protein co-treated with Mestranol] results in increased expression of MYC mRNAaffects cotreatment|increases expression 12632255
D005047 Etoposide [EGF protein results in decreased expression of TOP2A protein] which results in decreased susceptibility to Etoposidedecreases expression|decreases response to substance 16969495
D015073 2-Acetylaminofluorene 2-Acetylaminofluorene affects the reaction [EGF protein results in increased phosphorylation of EGFR protein]affects reaction|increases phosphorylation 10900465
D015073 2-Acetylaminofluorene 2-Acetylaminofluorene results in decreased localization of EGF proteindecreases localization 10900465
D005480 Flurbiprofen Flurbiprofen results in increased expression of EGF mRNAincreases expression 16949054
D005620 Freund's Adjuvant [Urethane co-treated with Freund's Adjuvant] results in increased expression of EGF mRNAaffects cotreatment|increases expression 12400877
D005632 Fructose EGF protein results in increased uptake of Fructoseincreases uptake 15691865
D005632 Fructose wortmannin inhibits the reaction [EGF protein results in increased uptake of Fructose]decreases reaction|increases uptake 15691865
C070081 fulvestrant fulvestrant affects the activity of EGF proteinaffects activity 19395996
C070081 fulvestrant fulvestrant inhibits the reaction [[4-hydroxytamoxifen co-treated with EGF protein] results in increased expression of CDH1 protein]affects cotreatment|decreases reaction|increases expression 19593637
C070081 fulvestrant fulvestrant inhibits the reaction [EGF protein results in increased expression of PLAUR protein]decreases reaction|increases expression 19395996
C419708 gefitinib gefitinib inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein]decreases reaction|increases phosphorylation 19233551
C419708 gefitinib gefitinib inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of EGFR protein]decreases reaction|increases activity|increases phosphorylation 17898861
C419708 gefitinib gefitinib inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of ERBB2 protein]decreases reaction|increases activity|increases phosphorylation 17898861
C419708 gefitinib gefitinib inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]decreases reaction|increases activity|increases phosphorylation 17898861
C419708 gefitinib gefitinib inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of MAPK3 protein]decreases reaction|increases activity|increases phosphorylation 17898861
C419708 gefitinib gefitinib inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]decreases reaction|increases phosphorylation 16243822
C419708 gefitinib gefitinib inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]decreases reaction|increases phosphorylation 19233551
C419708 gefitinib gefitinib inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]decreases reaction|increases phosphorylation 19233551
C419708 gefitinib gefitinib promotes the reaction [Hydrocortisone inhibits the reaction [EGF protein results in increased abundance of Dinoprostone]]decreases reaction|increases abundance|increases reaction 17805209
D019833 Genistein Genistein inhibits the reaction [EGF protein results in increased activity of AKT1 protein]decreases reaction|increases activity 18431742
D005839 Gentamicins Gentamicins results in decreased expression of EGF mRNAdecreases expression 18289764
D005978 Glutathione EGF protein affects the abundance of Glutathioneaffects abundance 10544272
D005984 Glutethimide [EGF protein co-treated with Glutethimide] results in increased expression of MYC mRNAaffects cotreatment|increases expression 12632255
C081021 Go 6976 Go 6976 inhibits the reaction [EGF protein binds to and results in increased localization of EGFR protein]affects binding|decreases reaction|increases localization 11134345
D006854 Hydrocortisone gefitinib promotes the reaction [Hydrocortisone inhibits the reaction [EGF protein results in increased abundance of Dinoprostone]]decreases reaction|increases abundance|increases reaction 17805209
D006854 Hydrocortisone Hydrocortisone inhibits the reaction [EGF protein results in increased abundance of Dinoprostone]decreases reaction|increases abundance 17805209
D006854 Hydrocortisone Hydrocortisone inhibits the reaction [EGF protein results in increased expression of PTGS2 mRNA]decreases reaction|increases expression 17805209
D006854 Hydrocortisone Indomethacin promotes the reaction [Hydrocortisone inhibits the reaction [EGF protein results in increased abundance of Dinoprostone]]decreases reaction|increases abundance|increases reaction 17805209
D006854 Hydrocortisone PD 98059 promotes the reaction [Hydrocortisone inhibits the reaction [EGF protein results in increased abundance of Dinoprostone]]decreases reaction|increases abundance|increases reaction 17805209
D006861 Hydrogen Peroxide Hydrogen Peroxide results in decreased expression of EGF mRNAdecreases expression 17997286
D006861 Hydrogen Peroxide Sodium Selenite inhibits the reaction [Hydrogen Peroxide results in decreased expression of EGF mRNA]decreases expression|decreases reaction 17997286
D003900 Desoxycorticosterone 4,5-dianilinophthalimide inhibits the reaction [EGF protein results in increased susceptibility to Desoxycorticosterone]decreases reaction|increases response to substance 11751714
D003900 Desoxycorticosterone EGF protein results in increased susceptibility to Desoxycorticosteroneincreases response to substance 11751714
D003900 Desoxycorticosterone tyrphostin AG 1478 inhibits the reaction [EGF protein results in increased susceptibility to Desoxycorticosterone]decreases reaction|increases response to substance 11751714
D007052 Ibuprofen Ibuprofen inhibits the reaction [EGF protein results in increased activity of MMP9 protein]decreases reaction|increases activity 16340751
D007052 Ibuprofen Ibuprofen inhibits the reaction [EGF protein results in increased expression of MMP9 mRNA]decreases reaction|increases expression 16340751
D007052 Ibuprofen Ibuprofen inhibits the reaction [EGF protein results in increased expression of PLAU mRNA]decreases reaction|increases expression 16340751
C051781 ICI 164384 ICI 164384 inhibits the reaction [EGF protein promotes the reaction [Estradiol results in increased expression of OLFM4 mRNA]]decreases reaction|increases expression|increases reaction 21048224
D007213 Indomethacin Indomethacin inhibits the reaction [EGF protein affects the localization of PTK2 protein]affects localization|decreases reaction 12037131
D007213 Indomethacin Indomethacin inhibits the reaction [EGF protein results in increased phosphorylation of PTK2 protein]decreases reaction|increases phosphorylation 12037131
D007213 Indomethacin Indomethacin promotes the reaction [Hydrocortisone inhibits the reaction [EGF protein results in increased abundance of Dinoprostone]]decreases reaction|increases abundance|increases reaction 17805209
D007213 Indomethacin allylpyrocatechol promotes the reaction [Indomethacin results in increased expression of EGF protein]increases expression|increases reaction 18431645
D007213 Indomethacin Indomethacin results in increased expression of EGF proteinincreases expression 18431645
18237397
D007213 Indomethacin Omeprazole promotes the reaction [Indomethacin results in increased expression of EGF protein]increases expression|increases reaction 18431645
D007213 Indomethacin Plant Extracts promotes the reaction [Indomethacin results in increased expression of EGF protein]increases expression|increases reaction 18237397
D007444 Inulin EGF protein inhibits the reaction [Acetaldehyde results in increased transport of Inulin]decreases reaction|increases transport 17991733
D007444 Inulin PRKCB protein affects the reaction [EGF protein inhibits the reaction [Acetaldehyde results in increased transport of Inulin]]affects reaction|decreases reaction|increases transport 17991733
D007444 Inulin PRKCE protein affects the reaction [EGF protein inhibits the reaction [Acetaldehyde results in increased transport of Inulin]]affects reaction|decreases reaction|increases transport 17991733
D015056 1-Methyl-3-isobutylxanthine EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ARHGAP5 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D015056 1-Methyl-3-isobutylxanthine EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CALML4 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D015056 1-Methyl-3-isobutylxanthine EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CLEC3B mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D015056 1-Methyl-3-isobutylxanthine EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of FAS mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D015056 1-Methyl-3-isobutylxanthine EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of FGF7 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D015056 1-Methyl-3-isobutylxanthine EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of FZD2 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D015056 1-Methyl-3-isobutylxanthine EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of IIGP1 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D015056 1-Methyl-3-isobutylxanthine EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of KLF5 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D015056 1-Methyl-3-isobutylxanthine EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of MARCKS mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D015056 1-Methyl-3-isobutylxanthine EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of PDGFRB mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D015056 1-Methyl-3-isobutylxanthine EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of PLTP mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D015056 1-Methyl-3-isobutylxanthine EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of TNFRSF11B mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D015056 1-Methyl-3-isobutylxanthine EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ACSL1 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D015056 1-Methyl-3-isobutylxanthine EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of GPAM mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D015056 1-Methyl-3-isobutylxanthine EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of HK2 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D015056 1-Methyl-3-isobutylxanthine EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of IRS2 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D015056 1-Methyl-3-isobutylxanthine EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of MGST1 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D015056 1-Methyl-3-isobutylxanthine EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ORM1 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D015056 1-Methyl-3-isobutylxanthine EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ORM2 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D015056 1-Methyl-3-isobutylxanthine EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ORM3 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D015056 1-Methyl-3-isobutylxanthine EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of SCD1 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D015056 1-Methyl-3-isobutylxanthine EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of SLC4A4 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D015056 1-Methyl-3-isobutylxanthine EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of SREBF1 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D015056 1-Methyl-3-isobutylxanthine EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of TEAD4 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D015056 1-Methyl-3-isobutylxanthine EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of XDH mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D015056 1-Methyl-3-isobutylxanthine [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of AHR mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D015056 1-Methyl-3-isobutylxanthine [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CCL2 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D015056 1-Methyl-3-isobutylxanthine [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CP mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D015056 1-Methyl-3-isobutylxanthine [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CXCL12 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D015056 1-Methyl-3-isobutylxanthine [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CXCL1 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D015056 1-Methyl-3-isobutylxanthine [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CXCL5 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D015056 1-Methyl-3-isobutylxanthine [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of EMP1 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D015056 1-Methyl-3-isobutylxanthine [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of IFI47 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D015056 1-Methyl-3-isobutylxanthine [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of IFNAR2 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D015056 1-Methyl-3-isobutylxanthine [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of KLF4 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D015056 1-Methyl-3-isobutylxanthine [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of TIMP1 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D015056 1-Methyl-3-isobutylxanthine [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of WISP2 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D015056 1-Methyl-3-isobutylxanthine [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ANGPTL4 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D015056 1-Methyl-3-isobutylxanthine [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CDO1 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D015056 1-Methyl-3-isobutylxanthine [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPA mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D015056 1-Methyl-3-isobutylxanthine [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CELF2 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D015056 1-Methyl-3-isobutylxanthine [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of DGAT1 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D015056 1-Methyl-3-isobutylxanthine [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of DNAJB9 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D015056 1-Methyl-3-isobutylxanthine [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ENPP2 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D015056 1-Methyl-3-isobutylxanthine [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of EPHX2 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D015056 1-Methyl-3-isobutylxanthine [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D015056 1-Methyl-3-isobutylxanthine [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FGFR2 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D015056 1-Methyl-3-isobutylxanthine [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of GADD45G mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D015056 1-Methyl-3-isobutylxanthine [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of HP mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D015056 1-Methyl-3-isobutylxanthine [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of IGFBP3 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D015056 1-Methyl-3-isobutylxanthine [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of IGFBP5 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D015056 1-Methyl-3-isobutylxanthine [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of MAPK4 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D015056 1-Methyl-3-isobutylxanthine [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of NAMPT mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D015056 1-Methyl-3-isobutylxanthine [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PLIN2 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D015056 1-Methyl-3-isobutylxanthine [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D015056 1-Methyl-3-isobutylxanthine [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PTP4A1 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D015056 1-Methyl-3-isobutylxanthine [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of TOB1 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D047311 Luteolin EGF protein inhibits the reaction [Luteolin results in decreased phosphorylation of PTK2 protein]decreases phosphorylation|decreases reaction 15135307
D047311 Luteolin Luteolin inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of EGFR protein]decreases reaction|increases activity|increases phosphorylation 15135307
D047311 Luteolin Luteolin inhibits the reaction [EGF protein results in increased phosphorylation of PTK2 protein]decreases reaction|increases phosphorylation 15135307
D047311 Luteolin Luteolin inhibits the reaction [EGF protein results in increased secretion of MMP9 protein]decreases reaction|increases secretion 15135307
C013598 methoxyacetic acid methoxyacetic acid promotes the reaction [EGF protein results in increased activity of ELK1 protein]increases activity|increases reaction 15103026
C013598 methoxyacetic acid U 0126 inhibits the reaction [methoxyacetic acid promotes the reaction [EGF protein results in increased activity of ELK1 protein]]decreases reaction|increases activity|increases reaction 15103026
D015735 Mifepristone Mifepristone inhibits the reaction [Progesterone promotes the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]]decreases reaction|increases phosphorylation|increases reaction 16175315
D015735 Mifepristone Mifepristone inhibits the reaction [Progesterone promotes the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]]decreases reaction|increases phosphorylation|increases reaction 16175315
D008985 Monensin [EGF protein co-treated with Monensin] results in increased expression of MYC mRNAaffects cotreatment|increases expression 12632255
D009151 Mustard Gas Mustard Gas results in increased expression of EGF proteinincreases expression 17266442
C040015 myricetin myricetin inhibits the reaction [EGF protein results in increased expression of FOS mRNA]decreases reaction|increases expression 17693661
C040015 myricetin myricetin inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]decreases reaction|increases phosphorylation 17693661
C040015 myricetin myricetin inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]decreases reaction|increases phosphorylation 17693661
C040015 myricetin myricetin inhibits the reaction [EGF protein results in increased phosphorylation of MAPK9 protein]decreases reaction|increases phosphorylation 17693661
C040015 myricetin myricetin inhibits the reaction [EGF protein results in increased phosphorylation of RPS6KA1 protein]decreases reaction|increases phosphorylation 17693661
C063509 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [EGF protein promotes the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]]decreases reaction|increases reaction|increases uptake 15238352
D009255 Nafenopin [EGF protein co-treated with Nafenopin] results in increased expression of MYC mRNAaffects cotreatment|increases expression 12632255
D019829 Nevirapine Nevirapine results in decreased expression of EGF mRNAdecreases expression 19152342
C007350 nitrofen nitrofen results in decreased expression of EGF mRNAdecreases expression 11409163
C510003 nordy nordy inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]decreases reaction|increases phosphorylation 17377739
D009638 Norepinephrine [EGF protein co-treated with Norepinephrine] results in increased expression of MYC mRNAaffects cotreatment|increases expression 12632255
D009853 Omeprazole Omeprazole promotes the reaction [Indomethacin results in increased expression of EGF protein]increases expression|increases reaction 18431645
C029341 oxophenylarsine oxophenylarsine inhibits the reaction [EGF protein affects the localization of and results in increased activity of STAT3 protein]affects localization|decreases reaction|increases activity 12093727
C029341 oxophenylarsine oxophenylarsine inhibits the reaction [EGF protein binds to and affects the localization of EGFR protein]affects binding|affects localization|decreases reaction 12093727
C093973 PD 98059 PD 98059 inhibits the reaction [EGF protein results in increased phosphorylation of RPS6KB1 protein]decreases reaction|increases phosphorylation 11959800
C093973 PD 98059 PD 98059 inhibits the reaction [[4-hydroxytamoxifen co-treated with EGF protein] results in increased expression of CDH1 protein]affects cotreatment|decreases reaction|increases expression 19593637
C093973 PD 98059 PD 98059 inhibits the reaction [EGF protein affects the localization of ESR1 protein]affects localization|decreases reaction 15947004
C093973 PD 98059 PD 98059 inhibits the reaction [EGF protein affects the localization of PRKCA protein]affects localization|decreases reaction 15613483
C093973 PD 98059 PD 98059 inhibits the reaction [EGF protein results in increased expression of AQP3 protein]decreases reaction|increases expression 18214481
C093973 PD 98059 PD 98059 inhibits the reaction [EGF protein results in increased expression of FOS protein]decreases reaction|increases expression 19749156
C093973 PD 98059 PD 98059 inhibits the reaction [EGF protein results in increased expression of GPR30 protein]decreases reaction|increases expression 19749156
C093973 PD 98059 PD 98059 inhibits the reaction [EGF protein results in increased expression of MUC5AC mRNA]decreases reaction|increases expression 15531749
C093973 PD 98059 PD 98059 inhibits the reaction [EGF protein results in increased phosphorylation of CREB1 protein]decreases reaction|increases phosphorylation 15466214
C093973 PD 98059 PD 98059 inhibits the reaction [EGF protein results in increased phosphorylation of MAP2K1 protein]decreases reaction|increases phosphorylation 15466214
C093973 PD 98059 PD 98059 inhibits the reaction [EGF protein results in increased phosphorylation of MAP2K2 protein]decreases reaction|increases phosphorylation 15466214
C093973 PD 98059 PD 98059 inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]decreases reaction|increases phosphorylation 15531749
15466214
C093973 PD 98059 PD 98059 inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]decreases reaction|increases phosphorylation 15466214
15531749
C093973 PD 98059 PD 98059 inhibits the reaction [EGF protein results in increased phosphorylation of MAPK8 protein]decreases reaction|increases phosphorylation 15531749
C093973 PD 98059 PD 98059 inhibits the reaction [FOS protein results in increased expression of EGF mRNA]decreases reaction|increases expression 15466214
C093973 PD 98059 PD 98059 promotes the reaction [Hydrocortisone inhibits the reaction [EGF protein results in increased abundance of Dinoprostone]]decreases reaction|increases abundance|increases reaction 17805209
C093973 PD 98059 PD 98059 inhibits the reaction [EGF protein affects the localization of and results in increased activity of CAPN2 protein]affects localization|decreases reaction|increases activity 16809781
C023036 perfluorooctanoic acid perfluorooctanoic acid affects the expression of EGF mRNAaffects expression 17132714
D026023 Permethrin EGF protein inhibits the reaction [Permethrin results in increased expression of CYP2B1 mRNA]decreases reaction|increases expression 14722249
11377398
D026023 Permethrin EGF protein inhibits the reaction [Permethrin results in increased expression of CYP3A1 mRNA]decreases reaction|increases expression 11377398
D010545 Peroxides Acetylcysteine inhibits the reaction [EGF protein results in increased abundance of Peroxides]decreases reaction|increases abundance 11158190
D010545 Peroxides EGF protein results in increased abundance of Peroxidesincreases abundance 11158190
D010545 Peroxides Selenium inhibits the reaction [EGF protein results in increased abundance of Peroxides]decreases reaction|increases abundance 11158190
D010622 Phencyclidine Phencyclidine results in increased expression of EGF mRNAincreases expression 12105081
D010634 Phenobarbital EGF protein inhibits the reaction [Phenobarbital results in increased expression of CYP2B1 mRNA]decreases reaction|increases expression 11377398
14722249
D010656 Phenylephrine ADAM17 protein affects the reaction [Phenylephrine results in increased cleavage of and results in increased secretion of EGF protein]affects reaction|increases cleavage|increases secretion 16760267
D010656 Phenylephrine [EGF protein binds to EGFR protein] promotes the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein]affects binding|increases phosphorylation|increases reaction 16760267
D010656 Phenylephrine [EGF protein binds to EGFR protein] promotes the reaction [Phenylephrine results in increased phosphorylation of MAPK3 protein]affects binding|increases phosphorylation|increases reaction 16760267
D010656 Phenylephrine Phenylephrine results in increased cleavage of and results in increased secretion of EGF proteinincreases cleavage|increases secretion 16760267
D010712 Phosphatidic Acids 1-Butanol inhibits the reaction [EGF protein results in increased abundance of Phosphatidic Acids]decreases reaction|increases abundance 11134345
D010712 Phosphatidic Acids EGF protein results in increased abundance of Phosphatidic Acidsincreases abundance 11134345
C006253 pirinixic acid [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of EGF mRNAaffects binding|increases activity|increases expression 19710929
D010936 Plant Extracts Plant Extracts promotes the reaction [Indomethacin results in increased expression of EGF protein]increases expression|increases reaction 18237397
D011374 Progesterone Mifepristone inhibits the reaction [Progesterone promotes the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]]decreases reaction|increases phosphorylation|increases reaction 16175315
D011374 Progesterone Mifepristone inhibits the reaction [Progesterone promotes the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]]decreases reaction|increases phosphorylation|increases reaction 16175315
D011374 Progesterone Progesterone promotes the reaction [EGF protein affects the localization of FOS protein]affects localization|increases reaction 16175315
D011374 Progesterone Progesterone promotes the reaction [EGF protein results in increased expression of FOS mRNA]increases expression|increases reaction 16175315
D011374 Progesterone Progesterone promotes the reaction [EGF protein results in increased expression of FOS protein]increases expression|increases reaction 16175315
D011374 Progesterone Progesterone promotes the reaction [EGF protein results in increased phosphorylation of EGFR protein]increases phosphorylation|increases reaction 16175315
D011374 Progesterone Progesterone promotes the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]increases phosphorylation|increases reaction 16175315
D011374 Progesterone Progesterone promotes the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]increases phosphorylation|increases reaction 16175315
D011374 Progesterone U 0126 inhibits the reaction [Progesterone promotes the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]]decreases reaction|increases phosphorylation|increases reaction 16175315
D011374 Progesterone U 0126 inhibits the reaction [Progesterone promotes the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]]decreases reaction|increases phosphorylation|increases reaction 16175315
D015232 Dinoprostone EGF protein results in increased abundance of Dinoprostoneincreases abundance 17805209
D015232 Dinoprostone gefitinib promotes the reaction [Hydrocortisone inhibits the reaction [EGF protein results in increased abundance of Dinoprostone]]decreases reaction|increases abundance|increases reaction 17805209
D015232 Dinoprostone Hydrocortisone inhibits the reaction [EGF protein results in increased abundance of Dinoprostone]decreases reaction|increases abundance 17805209
D015232 Dinoprostone Indomethacin promotes the reaction [Hydrocortisone inhibits the reaction [EGF protein results in increased abundance of Dinoprostone]]decreases reaction|increases abundance|increases reaction 17805209
D015232 Dinoprostone PD 98059 promotes the reaction [Hydrocortisone inhibits the reaction [EGF protein results in increased abundance of Dinoprostone]]decreases reaction|increases abundance|increases reaction 17805209
D019269 Phosphatidylinositol 4,5-Diphosphate Phosphatidylinositol 4,5-Diphosphate affects the reaction [EGF protein results in increased activity of CAPN2 protein]affects reaction|increases activity 16809781
C020972 pyrrolidine dithiocarbamic acid pyrrolidine dithiocarbamic acid inhibits the reaction [EGF protein results in increased activity of MMP9 protein]decreases reaction|increases activity 16340751
C020972 pyrrolidine dithiocarbamic acid pyrrolidine dithiocarbamic acid inhibits the reaction [EGF protein results in increased expression of MMP9 mRNA]decreases reaction|increases expression 16340751
C020972 pyrrolidine dithiocarbamic acid pyrrolidine dithiocarbamic acid inhibits the reaction [EGF protein results in increased expression of PLAU mRNA]decreases reaction|increases expression 16340751
D011794 Quercetin EGF protein inhibits the reaction [Quercetin results in decreased phosphorylation of PTK2 protein]decreases phosphorylation|decreases reaction 15135307
D011794 Quercetin Quercetin inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein]decreases reaction|increases phosphorylation 16619521
D011794 Quercetin Quercetin inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of EGFR protein]decreases reaction|increases activity|increases phosphorylation 15135307
D011794 Quercetin Quercetin inhibits the reaction [EGF protein results in increased phosphorylation of PTK2 protein]decreases reaction|increases phosphorylation 15135307
D011794 Quercetin Quercetin inhibits the reaction [EGF protein results in increased secretion of MMP9 protein]decreases reaction|increases secretion 15135307
D011794 Quercetin Quercetin results in decreased expression of EGF proteindecreases expression 12469199
C059514 resveratrol 4'-N-benzoylstaurosporine inhibits the reaction [EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of TP53 protein]]decreases reaction|increases activity|increases localization|increases phosphorylation 15542774
C059514 resveratrol EGF protein inhibits the reaction [resveratrol inhibits the reaction [TP53 protein binds to MDM2 protein]]affects binding|decreases reaction 15542774
C059514 resveratrol EGF protein inhibits the reaction [resveratrol results in increased expression of FOS mRNA]decreases reaction|increases expression 15542774
C059514 resveratrol EGF protein inhibits the reaction [resveratrol results in increased expression of JUN mRNA]decreases reaction|increases expression 15542774
C059514 resveratrol EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK1 protein]decreases reaction|increases activity|increases localization|increases phosphorylation 15542774
C059514 resveratrol EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK3 protein]decreases reaction|increases activity|increases localization|increases phosphorylation 15542774
C059514 resveratrol EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of TP53 protein]decreases reaction|increases activity|increases localization|increases phosphorylation 15542774
C059514 resveratrol PRKCA protein affects the reaction [EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK1 protein]]affects reaction|decreases reaction|increases activity|increases localization|increases phosphorylation 15542774
C059514 resveratrol PRKCA protein affects the reaction [EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK3 protein]]affects reaction|decreases reaction|increases activity|increases localization|increases phosphorylation 15542774
C059514 resveratrol PRKCA protein affects the reaction [EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of TP53 protein]]affects reaction|decreases reaction|increases activity|increases localization|increases phosphorylation 15542774
C059514 resveratrol resveratrol inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of AKT1 protein]decreases reaction|increases activity|increases phosphorylation 16343977
C059514 resveratrol resveratrol inhibits the reaction [EGF protein results in increased phosphorylation of PDPK1 protein]decreases reaction|increases phosphorylation 16343977
C059514 resveratrol resveratrol promotes the reaction [EGF protein results in increased phosphorylation of EGFR protein]increases phosphorylation|increases reaction 16343977
C059514 resveratrol resveratrol results in decreased activity of EGF proteindecreases activity 16343977
C059514 resveratrol Staurosporine inhibits the reaction [EGF protein inhibits the reaction [resveratrol inhibits the reaction [TP53 protein binds to MDM2 protein]]]affects binding|decreases reaction 15542774
C059514 resveratrol Staurosporine inhibits the reaction [EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK1 protein]]decreases reaction|increases activity|increases localization|increases phosphorylation 15542774
C059514 resveratrol Staurosporine inhibits the reaction [EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK3 protein]]decreases reaction|increases activity|increases localization|increases phosphorylation 15542774
C059514 resveratrol Staurosporine inhibits the reaction [EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of TP53 protein]]decreases reaction|increases activity|increases localization|increases phosphorylation 15542774
C059514 resveratrol PTPN11 protein affects the reaction [resveratrol inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of AKT1 protein]]affects reaction|decreases reaction|increases activity|increases phosphorylation 15849355
C059514 resveratrol resveratrol inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein]decreases reaction|increases phosphorylation 16626303
15849355
C059514 resveratrol resveratrol inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased localization of GAB1 protein]decreases reaction|increases localization|increases phosphorylation 15849355
C059514 resveratrol resveratrol inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]decreases reaction|increases phosphorylation 16626303
C059514 resveratrol resveratrol inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]decreases reaction|increases phosphorylation 16626303
C064758 Ro 31-8220 Ro 31-8220 inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]decreases reaction|increases activity|increases phosphorylation 16877402
C064758 Ro 31-8220 Ro 31-8220 inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of MAPK3 protein]decreases reaction|increases activity|increases phosphorylation 16877402
C085989 Ro 32-0432 Ro 32-0432 inhibits the reaction [EGF protein inhibits the reaction [Acetaldehyde affects the localization of TJP1 protein]]affects localization|decreases reaction 17991733
C085989 Ro 32-0432 Ro 32-0432 inhibits the reaction [EGF protein results in decreased susceptibility to Acetaldehyde]decreases reaction|decreases response to substance 17991733
C089730 rosiglitazone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ARHGAP5 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
C089730 rosiglitazone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CALML4 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
C089730 rosiglitazone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CLEC3B mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
C089730 rosiglitazone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of FAS mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
C089730 rosiglitazone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of FGF7 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
C089730 rosiglitazone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of FZD2 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
C089730 rosiglitazone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of IIGP1 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
C089730 rosiglitazone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of KLF5 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
C089730 rosiglitazone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of MARCKS mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
C089730 rosiglitazone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of PDGFRB mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
C089730 rosiglitazone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of PLTP mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
C089730 rosiglitazone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of TNFRSF11B mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
C089730 rosiglitazone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ACSL1 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
C089730 rosiglitazone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of GPAM mRNA]affects cotreatment|decreases reaction|increases expression 16054899
C089730 rosiglitazone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of HK2 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
C089730 rosiglitazone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of IRS2 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
C089730 rosiglitazone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of MGST1 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
C089730 rosiglitazone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ORM1 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
C089730 rosiglitazone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ORM2 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
C089730 rosiglitazone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ORM3 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
C089730 rosiglitazone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of SCD1 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
C089730 rosiglitazone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of SLC4A4 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
C089730 rosiglitazone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of SREBF1 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
C089730 rosiglitazone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of TEAD4 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
C089730 rosiglitazone EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of XDH mRNA]affects cotreatment|decreases reaction|increases expression 16054899
C089730 rosiglitazone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of AHR mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
C089730 rosiglitazone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CCL2 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
C089730 rosiglitazone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CP mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
C089730 rosiglitazone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CXCL12 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
C089730 rosiglitazone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CXCL1 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
C089730 rosiglitazone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CXCL5 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
C089730 rosiglitazone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of EMP1 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
C089730 rosiglitazone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of IFI47 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
C089730 rosiglitazone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of IFNAR2 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
C089730 rosiglitazone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of KLF4 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
C089730 rosiglitazone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of TIMP1 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
C089730 rosiglitazone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of WISP2 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
C089730 rosiglitazone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ANGPTL4 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
C089730 rosiglitazone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CDO1 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
C089730 rosiglitazone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPA mRNA]affects cotreatment|decreases reaction|increases expression 16054899
C089730 rosiglitazone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CELF2 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
C089730 rosiglitazone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of DGAT1 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
C089730 rosiglitazone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of DNAJB9 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
C089730 rosiglitazone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ENPP2 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
C089730 rosiglitazone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of EPHX2 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
C089730 rosiglitazone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
C089730 rosiglitazone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FGFR2 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
C089730 rosiglitazone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of GADD45G mRNA]affects cotreatment|decreases reaction|increases expression 16054899
C089730 rosiglitazone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of HP mRNA]affects cotreatment|decreases reaction|increases expression 16054899
C089730 rosiglitazone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of IGFBP3 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
C089730 rosiglitazone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of IGFBP5 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
C089730 rosiglitazone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of MAPK4 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
C089730 rosiglitazone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of NAMPT mRNA]affects cotreatment|decreases reaction|increases expression 16054899
C089730 rosiglitazone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PLIN2 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
C089730 rosiglitazone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]affects cotreatment|decreases reaction|increases expression 16054899
C089730 rosiglitazone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PTP4A1 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
C089730 rosiglitazone [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of TOB1 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
C115461 SC 560 SC 560 inhibits the reaction [EGF protein promotes the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]]decreases reaction|increases reaction|increases uptake 15238352
D012643 Selenium Selenium inhibits the reaction [EGF protein results in increased abundance of 8-hydroxyguanosine]decreases reaction|increases abundance 11158190
D012643 Selenium Selenium inhibits the reaction [EGF protein results in increased abundance of Peroxides]decreases reaction|increases abundance 11158190
D020123 Sirolimus Sirolimus inhibits the reaction [EGF protein results in increased phosphorylation of RPS6KB1 protein]decreases reaction|increases phosphorylation 11959800
D020123 Sirolimus Sirolimus inhibits the reaction [EGF protein results in increased activity of RPS6KB1 protein]decreases reaction|increases activity 12960407
D020123 Sirolimus Sirolimus inhibits the reaction [EGF protein results in increased phosphorylation of RPS6KB1 protein]decreases reaction|increases phosphorylation 12960407
D020123 Sirolimus Sirolimus analog results in decreased activity of EGF proteindecreases activity 12406821
D012980 Sodium Salicylate Sodium Salicylate promotes the reaction [[EGF protein co-treated with IGF1 protein] results in increased phosphorylation of and results in increased activity of RPS6KB1 protein]affects cotreatment|increases activity|increases phosphorylation|increases reaction 10993886
D018038 Sodium Selenite Sodium Selenite inhibits the reaction [Hydrogen Peroxide results in decreased expression of EGF mRNA]decreases expression|decreases reaction 17997286
D019311 Staurosporine Staurosporine inhibits the reaction [EGF protein inhibits the reaction [resveratrol inhibits the reaction [TP53 protein binds to MDM2 protein]]]affects binding|decreases reaction 15542774
D019311 Staurosporine Staurosporine inhibits the reaction [EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK1 protein]]decreases reaction|increases activity|increases localization|increases phosphorylation 15542774
D019311 Staurosporine Staurosporine inhibits the reaction [EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK3 protein]]decreases reaction|increases activity|increases localization|increases phosphorylation 15542774
D019311 Staurosporine Staurosporine inhibits the reaction [EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of TP53 protein]]decreases reaction|increases activity|increases localization|increases phosphorylation 15542774
D014284 Triiodothyronine Triiodothyronine inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]decreases reaction|increases phosphorylation 16150908
D014284 Triiodothyronine Triiodothyronine inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]decreases reaction|increases phosphorylation 16150908
D013629 Tamoxifen Tamoxifen affects the activity of EGF proteinaffects activity 19395996
C003377 taxifolin taxifolin results in decreased expression of EGF mRNAdecreases expression 17541156
D013739 Testosterone EGF protein inhibits the reaction [AG 1879 inhibits the reaction [Testosterone results in increased phosphorylation of CREB1 protein]]decreases reaction|increases phosphorylation 17272394
D013739 Testosterone EGF protein inhibits the reaction [AG 1879 inhibits the reaction [Testosterone results in increased phosphorylation of MAPK1 protein]]decreases reaction|increases phosphorylation 17272394
D013739 Testosterone EGF protein inhibits the reaction [AG 1879 inhibits the reaction [Testosterone results in increased phosphorylation of MAPK3 protein]]decreases reaction|increases phosphorylation 17272394
D013749 Tetrachlorodibenzodioxin Tetrachlorodibenzodioxin results in increased expression of EGF mRNAincreases expression 20044593
D013749 Tetrachlorodibenzodioxin EGF protein results in decreased susceptibility to Tetrachlorodibenzodioxindecreases response to substance 14514962
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of AHR mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CCL2 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CP mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CXCL12 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CXCL1 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CXCL5 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of EMP1 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of IFI47 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of IFNAR2 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of KLF4 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of TIMP1 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of WISP2 mRNA]affects cotreatment|decreases expression|decreases reaction 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ANGPTL4 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CDO1 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPA mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CELF2 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of DGAT1 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of DNAJB9 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ENPP2 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of EPHX2 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FGFR2 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of GADD45G mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of HP mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of IGFBP3 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of IGFBP5 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of MAPK4 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of NAMPT mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PLIN2 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PTP4A1 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of TOB1 mRNA]affects cotreatment|decreases reaction|increases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] results in decreased expression of ANGPTL4 mRNAaffects cotreatment|decreases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] results in decreased expression of APCDD1 mRNAaffects cotreatment|decreases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] results in decreased expression of CDO1 mRNAaffects cotreatment|decreases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] results in decreased expression of CEBPA mRNAaffects cotreatment|decreases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] results in decreased expression of CELF2 mRNAaffects cotreatment|decreases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] results in decreased expression of DGAT1 mRNAaffects cotreatment|decreases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] results in decreased expression of DNAJB9 mRNAaffects cotreatment|decreases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] results in decreased expression of EPHX2 mRNAaffects cotreatment|decreases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] results in decreased expression of FABP4 mRNAaffects cotreatment|decreases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] results in decreased expression of FGFR2 mRNAaffects cotreatment|decreases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] results in decreased expression of GADD45G mRNAaffects cotreatment|decreases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] results in decreased expression of HP mRNAaffects cotreatment|decreases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] results in decreased expression of IDH1 mRNAaffects cotreatment|decreases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] results in decreased expression of IGFBP3 mRNAaffects cotreatment|decreases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] results in decreased expression of IGFBP5 mRNAaffects cotreatment|decreases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] results in decreased expression of MAPK4 mRNAaffects cotreatment|decreases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] results in decreased expression of NAMPT mRNAaffects cotreatment|decreases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] results in decreased expression of PLIN2 mRNAaffects cotreatment|decreases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] results in decreased expression of PPARG mRNAaffects cotreatment|decreases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] results in decreased expression of PTP4A1 mRNAaffects cotreatment|decreases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] results in decreased expression of TOB1 mRNAaffects cotreatment|decreases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] results in increased expression of AHR mRNAaffects cotreatment|increases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] results in increased expression of BMP4 mRNAaffects cotreatment|increases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] results in increased expression of CCL2 mRNAaffects cotreatment|increases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] results in increased expression of CP mRNAaffects cotreatment|increases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] results in increased expression of CXCL12 mRNAaffects cotreatment|increases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] results in increased expression of CXCL1 mRNAaffects cotreatment|increases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] results in increased expression of CXCL5 mRNAaffects cotreatment|increases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] results in increased expression of EMP1 mRNAaffects cotreatment|increases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] results in increased expression of FIGF mRNAaffects cotreatment|increases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] results in increased expression of IFNAR2 mRNAaffects cotreatment|increases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] results in increased expression of IGF1R mRNAaffects cotreatment|increases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] results in increased expression of KLF4 mRNAaffects cotreatment|increases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] results in increased expression of TIMP1 mRNAaffects cotreatment|increases expression 16054899
D013749 Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin co-treated with EGF protein] results in increased expression of WISP2 mRNAaffects cotreatment|increases expression 16054899
D013749 Tetrachlorodibenzodioxin Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of AQP1 mRNA]decreases reaction|increases expression 15667827
D013749 Tetrachlorodibenzodioxin Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of CCL7 mRNA]decreases reaction|increases expression 15667827
D013749 Tetrachlorodibenzodioxin Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of CEBPA mRNA]decreases reaction|increases expression 15667827
D013749 Tetrachlorodibenzodioxin Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of CEBPD mRNA]decreases reaction|increases expression 15667827
D013749 Tetrachlorodibenzodioxin Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of COL15A1 mRNA]decreases reaction|increases expression 15667827
D013749 Tetrachlorodibenzodioxin Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of COL3A1 mRNA]decreases reaction|increases expression 15667827
D013749 Tetrachlorodibenzodioxin Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of COL6A3 mRNA]decreases reaction|increases expression 15667827
D013749 Tetrachlorodibenzodioxin Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of CTSL mRNA]decreases reaction|increases expression 15667827
D013749 Tetrachlorodibenzodioxin Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of CX3CL1 mRNA]decreases reaction|increases expression 15667827
D013749 Tetrachlorodibenzodioxin Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of CXCL12 mRNA]decreases reaction|increases expression 15667827
D013749 Tetrachlorodibenzodioxin Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of CXCL1 mRNA]decreases reaction|increases expression 15667827
D013749 Tetrachlorodibenzodioxin Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of CXCL5 mRNA]decreases reaction|increases expression 15667827
D013749 Tetrachlorodibenzodioxin Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of DUSP1 mRNA]decreases reaction|increases expression 15667827
D013749 Tetrachlorodibenzodioxin Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of FGFR1 mRNA]decreases reaction|increases expression 15667827
D013749 Tetrachlorodibenzodioxin Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of ID1 mRNA]decreases reaction|increases expression 15667827
D013749 Tetrachlorodibenzodioxin Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of IL6 mRNA]decreases reaction|increases expression 15667827
D013749 Tetrachlorodibenzodioxin Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of KLF10 mRNA]decreases reaction|increases expression 15667827
D013749 Tetrachlorodibenzodioxin Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of KLF9 mRNA]decreases reaction|increases expression 15667827
D013749 Tetrachlorodibenzodioxin Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of LCN2 mRNA]decreases reaction|increases expression 15667827
D013749 Tetrachlorodibenzodioxin Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of NOTCH1 mRNA]decreases reaction|increases expression 15667827
D013749 Tetrachlorodibenzodioxin Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of P2RX4 mRNA]decreases reaction|increases expression 15667827
D013749 Tetrachlorodibenzodioxin Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of P4HA1 mRNA]decreases reaction|increases expression 15667827
D013749 Tetrachlorodibenzodioxin Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of PKIG mRNA]decreases reaction|increases expression 15667827
D013749 Tetrachlorodibenzodioxin Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of POSTN mRNA]decreases reaction|increases expression 15667827
D013749 Tetrachlorodibenzodioxin Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of PPP2R5D mRNA]decreases reaction|increases expression 15667827
D013749 Tetrachlorodibenzodioxin Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of SOD2 mRNA]decreases reaction|increases expression 15667827
D013749 Tetrachlorodibenzodioxin Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of TINAGL1 mRNA]decreases reaction|increases expression 15667827
D013749 Tetrachlorodibenzodioxin Tetrachlorodibenzodioxin results in increased expression of EGF mRNAincreases expression 20044593
D013749 Tetrachlorodibenzodioxin Tetrachlorodibenzodioxin results in decreased expression of EGF mRNAdecreases expression 18796159
D019284 Thapsigargin Thapsigargin inhibits the reaction [EGF protein affects the localization of PRKCB protein]affects localization|decreases reaction 17991733
C496197 trans-10,cis-12-conjugated linoleic acid trans-10,cis-12-conjugated linoleic acid results in increased expression of EGF mRNAincreases expression 17951470
D014212 Tretinoin EGF protein results in decreased activity of Tretinoindecreases activity 11171635
D014212 Tretinoin [Tretinoin co-treated with EGF protein co-treated with NOG protein] results in increased expression of SOX10 mRNAaffects cotreatment|increases expression 17196394
D014212 Tretinoin [Tretinoin co-treated with EGF protein] results in increased expression of NKX2-2 mRNAaffects cotreatment|increases expression 17196394
D014212 Tretinoin EGF protein inhibits the reaction [Tretinoin results in increased activity of ALPL protein]decreases reaction|increases activity 11171635
C101044 tyrphostin AG 1478 tyrphostin AG 1478 inhibits the reaction [EGF protein results in decreased expression of and results in decreased secretion of KLK3 protein]decreases expression|decreases reaction|decreases secretion 16472761
C101044 tyrphostin AG 1478 tyrphostin AG 1478 inhibits the reaction [EGF protein results in decreased expression of AR protein]decreases expression|decreases reaction 16472761
C101044 tyrphostin AG 1478 tyrphostin AG 1478 inhibits the reaction [EGF protein results in increased abundance of Calcium]decreases reaction|increases abundance 11527950
C101044 tyrphostin AG 1478 tyrphostin AG 1478 inhibits the reaction [EGF protein results in increased expression of FOS protein]decreases reaction|increases expression 19749156
C101044 tyrphostin AG 1478 tyrphostin AG 1478 inhibits the reaction [EGF protein results in increased expression of GPR30 protein]decreases reaction|increases expression 19749156
C101044 tyrphostin AG 1478 tyrphostin AG 1478 inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of AKT1 protein]decreases reaction|increases activity|increases phosphorylation 11309286
C101044 tyrphostin AG 1478 tyrphostin AG 1478 inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]decreases reaction|increases activity|increases phosphorylation 11309286
C101044 tyrphostin AG 1478 tyrphostin AG 1478 inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of MAPK3 protein]decreases reaction|increases activity|increases phosphorylation 11309286
C101044 tyrphostin AG 1478 tyrphostin AG 1478 inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]decreases reaction|increases phosphorylation 16472761
C101044 tyrphostin AG 1478 tyrphostin AG 1478 inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein]decreases reaction|increases phosphorylation 15849355
C101044 tyrphostin AG 1478 tyrphostin AG 1478 inhibits the reaction [EGF protein results in increased susceptibility to Desoxycorticosterone]decreases reaction|increases response to substance 11751714
C113580 U 0126 U 0126 inhibits the reaction [EGF protein results in increased expression of AQP3 protein]decreases reaction|increases expression 18214481
16848764
C113580 U 0126 U 0126 inhibits the reaction [methoxyacetic acid promotes the reaction [EGF protein results in increased activity of ELK1 protein]]decreases reaction|increases activity|increases reaction 15103026
C113580 U 0126 U 0126 inhibits the reaction [Progesterone promotes the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]]decreases reaction|increases phosphorylation|increases reaction 16175315
C113580 U 0126 U 0126 inhibits the reaction [Progesterone promotes the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]]decreases reaction|increases phosphorylation|increases reaction 16175315
C113580 U 0126 U 0126 inhibits the reaction [Valproic Acid promotes the reaction [EGF protein results in increased activity of ELK1 protein]]decreases reaction|increases activity|increases reaction 15103026
D014520 Urethane [Urethane co-treated with Freund's Adjuvant] results in increased expression of EGF mRNAaffects cotreatment|increases expression 12400877
D014520 Urethane Urethane results in increased expression of EGF mRNAincreases expression 12400877
D014635 Valproic Acid U 0126 inhibits the reaction [Valproic Acid promotes the reaction [EGF protein results in increased activity of ELK1 protein]]decreases reaction|increases activity|increases reaction 15103026
D014635 Valproic Acid Valproic Acid promotes the reaction [EGF protein results in increased activity of ELK1 protein]increases activity|increases reaction 15103026
D014640 Vancomycin Vancomycin results in decreased expression of EGF mRNAdecreases expression 18289764
C009687 wortmannin wortmannin inhibits the reaction [EGF protein results in increased phosphorylation of RPS6KB1 protein]decreases reaction|increases phosphorylation 11959800
C009687 wortmannin wortmannin inhibits the reaction [EGF protein results in increased phosphorylation of RPS6KB1 protein]decreases reaction|increases phosphorylation 12960407
C009687 wortmannin wortmannin inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein]decreases reaction|increases phosphorylation 15849355
C009687 wortmannin wortmannin inhibits the reaction [EGF protein results in increased uptake of Fructose]decreases reaction|increases uptake 15691865
D015032 Zinc EGF protein results in increased import of Zincincreases import 16443356
Disease ID Disease Name Direct Evidence Inference Chemical Name Inference Score Publication
MESH:D000008 Abdominal Neoplasms Tamoxifen 3.5314745880
MESH:D000014 Abnormalities, Drug-Induced methoxyacetic acid 12.363652986 1761404 1761407 15959878 12805644
MESH:D000014 Abnormalities, Drug-Induced Phenobarbital 12.366195326
MESH:D000014 Abnormalities, Drug-Induced Tetrachlorodibenzodioxin 12.3611752688 14514962 15322242
MESH:D000014 Abnormalities, Drug-Induced Valproic Acid 12.368875741
MESH:D000015 Abnormalities, Multiple Valproic Acid 3.0119490988
MESH:D000138 Acidosis Ammonium Chloride 2.5718287403
MESH:D000168 Acrocephalosyndactylia U 0126 4.5017694057
MESH:D000169 Acrodermatitis Zinc 4.4016889938 17190629 17202136
MESH:D058186 Acute Kidney Injury Cisplatin 17.3417670903 15814532 12690470
MESH:D058186 Acute Kidney Injury Desoxycorticosterone 17.3419564549
MESH:D058186 Acute Kidney Injury Gentamicins 17.3411274264
MESH:D058186 Acute Kidney Injury Ibuprofen 17.346375363
MESH:D058186 Acute Kidney Injury resveratrol 17.3416538975
MESH:D055371 Acute Lung Injury pirinixic acid 2.2018653653
MESH:D000230 Adenocarcinoma 1,2-Dimethylhydrazine 23.781933837 1113308
MESH:D000230 Adenocarcinoma arsenic trioxide 23.7819825857 11798837
MESH:D000230 Adenocarcinoma Cisplatin 23.7811798837 17638652
MESH:D000230 Adenocarcinoma Dimethylnitrosamine 23.7816033868
MESH:D000230 Adenocarcinoma Doxorubicin 23.7817418594
MESH:D000230 Adenocarcinoma Estradiol 23.7811473722
MESH:D000230 Adenocarcinoma Genistein 23.7811473722
MESH:D000230 Adenocarcinoma Ibuprofen 23.7810697514
MESH:D000230 Adenocarcinoma Indomethacin 23.7816537180
MESH:D000230 Adenocarcinoma Urethane 23.7818316556
MESH:D002282 Adenocarcinoma, Bronchiolo-Alveolar Urethane 4.6915814487
MESH:D000236 Adenoma 2-Acetylaminofluorene 21.1910737359
MESH:D000236 Adenoma 4,4'-diaminodiphenylmethane 21.193712494
MESH:D000236 Adenoma Diethylnitrosamine 21.1910737359 6695378
MESH:D000236 Adenoma Dimethylnitrosamine 21.1919555203
MESH:D000236 Adenoma Indomethacin 21.1911497255
MESH:D000236 Adenoma resveratrol 21.1915688382
MESH:D000236 Adenoma Urethane 21.1916926031 11497255 10822126 17093202 6695378 10530776 17195641
MESH:D002759 Adenoma, Bile Duct 2-Acetylaminofluorene 4.996705139
MESH:D018248 Adenoma, Liver Cell DDT 22.2712597452
MESH:D018248 Adenoma, Liver Cell Diethylnitrosamine 22.2716434500 19052882 17162532 19061943 18056438 17620307
MESH:D018248 Adenoma, Liver Cell Phenobarbital 22.2717620307
MESH:D018248 Adenoma, Liver Cell pirinixic acid 22.2716434500
MESH:D018248 Adenoma, Liver Cell Tetrachlorodibenzodioxin 22.2716835633
MESH:D011125 Adenomatous Polyposis Coli Dinoprostone 7.5017942926
MESH:D011125 Adenomatous Polyposis Coli Flurbiprofen 7.5010680582
MESH:D000382 Agricultural Workers' Diseases DDT 3.7316487989 12584743
MESH:D000419 Albuminuria Doxorubicin 3.5821441931
MESH:D019973 Alcohol-Related Disorders Curcumin 4.0617887948
MESH:D000505 Alopecia Tretinoin 2.7815955085
MESH:D016301 Alveolar Bone Loss Indomethacin 4.3517225004
MESH:D000544 Alzheimer Disease Curcumin 13.4915590663
MESH:D000544 Alzheimer Disease Ibuprofen 13.4918351690
MESH:D000544 Alzheimer Disease Indomethacin 13.4917627676 15579461
MESH:D000544 Alzheimer Disease Plant Extracts 13.4916962711
MESH:D000544 Alzheimer Disease resveratrol 13.4916183991 16162502
MESH:D000544 Alzheimer Disease rosiglitazone 13.4919621015
MESH:D000544 Alzheimer Disease Zinc 13.4916410023 17119284 16325427 16580781
MESH:D000550 Amblyopia Valproic Acid 4.2117688650
MESH:D000686 Amyloidosis Diethylstilbestrol 3.5215469931
MESH:D000707 Anaphylaxis Ibuprofen 4.279532969
MESH:D000740 Anemia Tetrachlorodibenzodioxin 2.0611748828
MESH:D000743 Anemia, Hemolytic Quercetin 3.3217084956
MESH:D000755 Anemia, Sickle Cell Zinc 3.9416916123
MESH:D000799 Angioedema Acetaminophen 2.8310982225
MESH:D000987 Antisocial Personality Disorder Testosterone 4.847506515
MESH:D001008 Anxiety Disorders Valproic Acid 2.7417497229
MESH:D001014 Aortic Aneurysm Dinoprostone 9.0210231640
MESH:D001014 Aortic Aneurysm Indomethacin 9.0210231640
MESH:D017544 Aortic Aneurysm, Abdominal Dinoprostone 9.0310388637
MESH:D017544 Aortic Aneurysm, Abdominal Indomethacin 9.0310388637
MESH:D001145 Arrhythmias, Cardiac Phenylephrine 3.2317460149
MESH:D018771 Arthralgia Indomethacin 4.152160914
MESH:D001169 Arthritis, Experimental Dexamethasone 11.7217659584
MESH:D001169 Arthritis, Experimental Plant Extracts 11.7214686799
MESH:D001169 Arthritis, Experimental resveratrol 11.7217115116
MESH:D001169 Arthritis, Experimental Tretinoin 11.7216412693
MESH:D001172 Arthritis, Rheumatoid Curcumin 5.2316807698
MESH:D001172 Arthritis, Rheumatoid Indomethacin 5.2311248219
MESH:D001172 Arthritis, Rheumatoid Tretinoin 5.2316292516
MESH:D001249 Asthma Acetaldehyde 10.079600491
MESH:D001249 Asthma epigallocatechin gallate 10.0716516891
MESH:D001249 Asthma Mustard Gas 10.0710378619
MESH:D001249 Asthma Tretinoin 10.0716456186
MESH:D001249 Asthma Zinc 10.0717085522
MESH:D001259 Ataxia 1-Butanol 4.647820390
MESH:D001260 Ataxia Telangiectasia Quercetin 3.9715336622
MESH:D050197 Atherosclerosis Curcumin 4.6218704882
MESH:D050197 Atherosclerosis resveratrol 4.6216873680 17967414
MESH:D001284 Atrophy fulvestrant 3.8911514358
MESH:D001321 Autistic Disorder marker/mechanism 17626784
MESH:D001321 Autistic Disorder Acetaminophen 2.5818445737
MESH:D001321 Autistic Disorder Glutathione 2.5818929414 16917939 19267885 19056591
MESH:D001321 Autistic Disorder Norepinephrine 2.588570775
MESH:D001321 Autistic Disorder Sirolimus 2.5821115397
MESH:D001321 Autistic Disorder Valproic Acid 2.5818396377 17688650 19232924 18177632 19460635 16609825 15238991 18775368 18558336 18940202 18316065 17157402 20603192 17507914 18985861
MESH:D001327 Autoimmune Diseases Curcumin 12.5519761891
MESH:D001327 Autoimmune Diseases epigallocatechin gallate 12.5519761891
MESH:D001327 Autoimmune Diseases Quercetin 12.5519761891
MESH:D001471 Barrett Esophagus Tretinoin 3.4416935849
MESH:D001477 Bartter Syndrome Dinoprostone 9.4515976003
MESH:D001477 Bartter Syndrome Indomethacin 9.4510684365
MESH:D001660 Biliary Tract Diseases 4,4'-diaminodiphenylmethane 4.0011289319 1440618
MESH:D001714 Bipolar Disorder Valproic Acid 2.4517594078 20046352
MESH:D001768 Blister Mustard Gas 4.1619167455
MESH:D001778 Blood Coagulation Disorders arsenic trioxide 19.2416206674
MESH:D001778 Blood Coagulation Disorders Omeprazole 19.2419483382
MESH:D001778 Blood Coagulation Disorders pirinixic acid 19.2419483382
MESH:D001778 Blood Coagulation Disorders Tetrachlorodibenzodioxin 19.2412125929
MESH:D001778 Blood Coagulation Disorders Tretinoin 19.2416206674 16197459
MESH:D001836 Body Weight Changes Tetrachlorodibenzodioxin 2.7815340226
MESH:D001848 Bone Diseases, Developmental Tetrachlorodibenzodioxin 5.5615746008
MESH:D001848 Bone Diseases, Developmental Valproic Acid 5.568888407
MESH:D019046 Bone Marrow Neoplasms Cisplatin 21.0514601052
MESH:D019046 Bone Marrow Neoplasms Dactinomycin 21.0514601052
MESH:D019046 Bone Marrow Neoplasms Doxorubicin 21.0514601052
MESH:D019046 Bone Marrow Neoplasms Etoposide 21.0514601052
MESH:D001862 Bone Resorption Freund's Adjuvant 4.2216769263
MESH:D001919 Bradycardia Phenylephrine 3.5515306635
MESH:D001929 Brain Edema Indomethacin 4.0111481608
MESH:D020201 Brain Hemorrhage, Traumatic Progesterone 4.3217868700
MESH:D001930 Brain Injuries Progesterone 7.8015665606 15845082 15380490
MESH:D001930 Brain Injuries Zinc 7.8017109824
MESH:D002545 Brain Ischemia Curcumin 21.3216770732
MESH:D002545 Brain Ischemia Ibuprofen 21.3215837124
MESH:D002545 Brain Ischemia Indomethacin 21.3212524144
MESH:D002545 Brain Ischemia Plant Extracts 21.3216041641
MESH:D002545 Brain Ischemia resveratrol 21.3217600658
MESH:D001932 Brain Neoplasms Curcumin 6.0117596214
MESH:D001932 Brain Neoplasms Doxorubicin 6.0117150277
MESH:D001943 Breast Neoplasms marker/mechanism 16175315
MESH:D001943 Breast Neoplasms bexarotene 19.3416818667 16344269
MESH:D001943 Breast Neoplasms Calcitriol 19.3411237771
MESH:D001943 Breast Neoplasms Cisplatin 19.3419526202 18382427
MESH:D001943 Breast Neoplasms Curcumin 19.3416243823 19250217 18462866 18593918
MESH:D001943 Breast Neoplasms DDT 19.3412709520 16792888
MESH:D001943 Breast Neoplasms Diethylnitrosamine 19.3417474063
MESH:D001943 Breast Neoplasms Diethylstilbestrol 19.3417129689 15324884
MESH:D001943 Breast Neoplasms Doxorubicin 19.3418628466 15634643 16264153 15668708 15939500 16826403 18695136 15136595 16096432 15994142 18234424 15993339 19526202 15692762 18382427 17426702 15567936 16595493 11325840 16935488 17983394 16322301 16115903 17369602
MESH:D001943 Breast Neoplasms Estradiol 19.3417289903 14630087 12948864 19861407 17018787 18497071 17261762 16675129
MESH:D001943 Breast Neoplasms estrone sulfate 19.3417261762
MESH:D001943 Breast Neoplasms Etoposide 19.3416322251
MESH:D001943 Breast Neoplasms fulvestrant 19.3418984771
MESH:D001943 Breast Neoplasms Genistein 19.3416873071 16541309 17200150
MESH:D001943 Breast Neoplasms Indomethacin 19.3417401462
MESH:D001943 Breast Neoplasms Progesterone 19.3415562024 17614352 16175315
MESH:D001943 Breast Neoplasms Quercetin 19.3418628248
MESH:D001943 Breast Neoplasms resveratrol 19.3417534123 17651959 16393696
MESH:D001943 Breast Neoplasms Tamoxifen 19.3419066611 16202921 20390343 17893378 20005174 16273361 18984771 17242785 18997820 18629630 20065188 19115204 17261762 19189212 16818667 19084267 21152245 19155303 19103187 19059307 19200415 20135344 17440819 19011961 18821012 19221464 19244106 18855134 20859285 11161223 19289846 18351453 18425577 19189210 16873071 19142967 20544844 18815881 15668708 19288272 19410462 17049068 19487384 15565566 21138602
MESH:D001943 Breast Neoplasms Testosterone 19.3417261762
MESH:D001943 Breast Neoplasms Tetrachlorodibenzodioxin 19.3420435547
MESH:D001943 Breast Neoplasms Tretinoin 19.3416443354 16873071 16166294
MESH:D016535 Bronchial Hyperreactivity tyrphostin AG 1478 4.0612794006
MESH:D001989 Bronchiolitis Obliterans Mustard Gas 4.1615286001
MESH:D029481 Bronchitis, Chronic Mustard Gas 3.9617687719 10378619
MESH:D001997 Bronchopulmonary Dysplasia Tretinoin 3.5916813970
MESH:D002051 Burkitt Lymphoma arsenic trioxide 3.3911589617
MESH:D002056 Burns Indomethacin 3.7310459503
MESH:D002057 Burns, Chemical Plant Extracts 4.329625245
MESH:D002100 Cachexia Ibuprofen 9.3515141370
MESH:D002100 Cachexia Indomethacin 9.3515141370 16537180 11239499 15625704
MESH:D002105 Cadmium Poisoning Quercetin 4.5216962696
MESH:D002181 Candidiasis, Vulvovaginal Estradiol 3.4616111702
MESH:D002252 Carbon Tetrachloride Poisoning Carbon Tetrachloride 2.8116011737 15721981 16124888 15673190 16050911 16227642 16097048 18705752 10355542 15700767 3786805 16192424
MESH:D002276 Carcinoid Tumor Doxorubicin 3.7916051944
MESH:D002277 Carcinoma Curcumin 9.1918593918
MESH:D002277 Carcinoma Dimethylnitrosamine 9.1919555203
MESH:D002277 Carcinoma Tetrachlorodibenzodioxin 9.1916835633
MESH:D018270 Carcinoma, Ductal, Breast Tamoxifen 3.5219066611
MESH:D018236 Carcinoma, Embryonal Tretinoin 4.1416168501
MESH:D006528 Carcinoma, Hepatocellular marker/mechanism 9029167
MESH:D006528 Carcinoma, Hepatocellular 2,4-dinitrotoluene 61.5316705839
MESH:D006528 Carcinoma, Hepatocellular 2,6-dinitrotoluene 61.5316705839
MESH:D006528 Carcinoma, Hepatocellular 2-Acetylaminofluorene 61.533084413 10737359 3581430 17761372 6705139
MESH:D006528 Carcinoma, Hepatocellular 4,4'-diaminodiphenylmethane 61.533581430 7296757
MESH:D006528 Carcinoma, Hepatocellular Acetaminophen 61.533084413
MESH:D006528 Carcinoma, Hepatocellular Aflatoxin B1 61.5321507988 12619106 12907637
MESH:D006528 Carcinoma, Hepatocellular anthra(1,9-cd)pyrazol-6(2H)-one 61.5319418558
MESH:D006528 Carcinoma, Hepatocellular arsenic trioxide 61.5314691202 15073043 16217749 15553829 11135700
MESH:D006528 Carcinoma, Hepatocellular Carbon Tetrachloride 61.5318788625
MESH:D006528 Carcinoma, Hepatocellular Cisplatin 61.5317982673
MESH:D006528 Carcinoma, Hepatocellular DDT 61.5312597452
MESH:D006528 Carcinoma, Hepatocellular Diethylnitrosamine 61.5317162532 18665156 16681979 19418558 19701751 18788625 16779866 20512989 19822196 20727157 21159647 18971187 19335982 16878318 19519916 18494052 16807293 10737359 19383236 20514400 11831363 20432363 20935162 3084413 16540662 16288022 20007298 19208518 18785209 17978847 17428255 17138121 18978308 19919837 20524982 17761372 16830150 17055752 16698587 17173139 20101231 10672840 19394651 16502159 18691550 16328049 19107877 18393292 20084675 16569478 18506893 19052882 3581430 19539802 18056438 16935385 20214788 18210153 19171122
MESH:D006528 Carcinoma, Hepatocellular Diethylstilbestrol 61.5315948411 16924424
MESH:D006528 Carcinoma, Hepatocellular Doxorubicin 61.5316234567 18059187 17876044 16023760
MESH:D006528 Carcinoma, Hepatocellular Estradiol 61.5316924424
MESH:D006528 Carcinoma, Hepatocellular Genistein 61.5316924424
MESH:D006528 Carcinoma, Hepatocellular Indomethacin 61.5316391822
MESH:D006528 Carcinoma, Hepatocellular Phenobarbital 61.531701930 6705139 17173139 20935162 20007298
MESH:D006528 Carcinoma, Hepatocellular Plant Extracts 61.5318834353
MESH:D006528 Carcinoma, Hepatocellular Quercetin 61.5312508355 19519916
MESH:D006528 Carcinoma, Hepatocellular resveratrol 61.5316227395 19321006
MESH:D006528 Carcinoma, Hepatocellular SC 560 61.5316391822
MESH:D006528 Carcinoma, Hepatocellular Sirolimus 61.5319335982
MESH:D006528 Carcinoma, Hepatocellular Tamoxifen 61.5316924424
MESH:D006528 Carcinoma, Hepatocellular Tretinoin 61.531917145
MESH:D018827 Carcinoma, Lewis Lung Indomethacin 8.1211053908
MESH:D018827 Carcinoma, Lewis Lung resveratrol 8.1216675471
MESH:D018276 Carcinoma, Medullary Indomethacin 4.3514736730 11352223 18791128
MESH:D002289 Carcinoma, Non-Small-Cell Lung bexarotene 8.7116247446
MESH:D002289 Carcinoma, Non-Small-Cell Lung Cisplatin 8.7116685392 12023789
MESH:D002289 Carcinoma, Non-Small-Cell Lung Curcumin 8.7118414057
MESH:D002289 Carcinoma, Non-Small-Cell Lung gefitinib 8.7120005069 18347146 19233551 15496427 17290066 16230376
MESH:D021441 Carcinoma, Pancreatic Ductal Quercetin 3.9717234771
MESH:D002291 Carcinoma, Papillary arsenic trioxide 3.8519014326
MESH:D002292 Carcinoma, Renal Cell 4,4'-diaminodiphenylmethane 7.317296757
MESH:D002292 Carcinoma, Renal Cell Doxorubicin 7.3116201981 1485588
MESH:D002292 Carcinoma, Renal Cell Indomethacin 7.3117341418
MESH:D018288 Carcinoma, Small Cell arsenic trioxide 3.2212490120
MESH:D002294 Carcinoma, Squamous Cell Acetylcysteine 31.4817015178
MESH:D002294 Carcinoma, Squamous Cell Calcitriol 31.4811237771
MESH:D002294 Carcinoma, Squamous Cell Cisplatin 31.4817066447 18337622 6189445
MESH:D002294 Carcinoma, Squamous Cell Curcumin 31.4818462866
MESH:D002294 Carcinoma, Squamous Cell Dimethylnitrosamine 31.4816033868
MESH:D002294 Carcinoma, Squamous Cell Doxorubicin 31.486189445
MESH:D002294 Carcinoma, Squamous Cell Glutathione 31.4817015178
MESH:D002294 Carcinoma, Squamous Cell Indomethacin 31.4815482327 12636206
MESH:D002294 Carcinoma, Squamous Cell resveratrol 31.4816227395
MESH:D002294 Carcinoma, Squamous Cell Sirolimus 31.4819435901
MESH:D002294 Carcinoma, Squamous Cell Tretinoin 31.4816051514 16096774
MESH:D002294 Carcinoma, Squamous Cell Zinc 31.4816543248
MESH:D002295 Carcinoma, Transitional Cell Tamoxifen 2.7217572228
MESH:D006332 Cardiomegaly Desoxycorticosterone 18.1619564549
MESH:D006332 Cardiomegaly Norepinephrine 18.1611179087
MESH:D006332 Cardiomegaly Phenylephrine 18.1611179087 17124262 17287366 15728586 16170337 11754973
MESH:D006332 Cardiomegaly Plant Extracts 18.1617645561
MESH:D006332 Cardiomegaly Quercetin 18.1619794523
MESH:D006332 Cardiomegaly Tetrachlorodibenzodioxin 18.1618670907 18850075 16120746
MESH:D009202 Cardiomyopathies Doxorubicin 2.8017924179 16269455 16455267 17519947 17928571 17131338 16242529 15476868 16278810 16651473 16952015 17351982 17974986 16612575 17007740 17308081 17382496 16364871 18627295 17329180 16109756 16731534 15505089 15792986 15811867
MESH:D002310 Cardiomyopathy, Alcoholic Acetaldehyde 5.4610525098
MESH:D002311 Cardiomyopathy, Dilated Doxorubicin 2.4817334414 16243910
MESH:D002318 Cardiovascular Diseases Genistein 11.0816332659
MESH:D002318 Cardiovascular Diseases Hydrogen Peroxide 11.0816936243
MESH:D002318 Cardiovascular Diseases resveratrol 11.0815458977
MESH:D002318 Cardiovascular Diseases Zinc 11.0816936243
MESH:D002375 Catalepsy Norepinephrine 4.548216760
MESH:D002386 Cataract Acetaminophen 4.9110977129
MESH:D002386 Cataract Tretinoin 4.9117460283
MESH:D002471 Cell Transformation, Neoplastic 2,6-dinitrotoluene 20.206135515
MESH:D002471 Cell Transformation, Neoplastic 4,4'-diaminodiphenylmethane 20.207505956
MESH:D002471 Cell Transformation, Neoplastic Acetylcysteine 20.2018226522
MESH:D002471 Cell Transformation, Neoplastic Cyclosporine 20.2012371664
MESH:D002471 Cell Transformation, Neoplastic Diethylnitrosamine 20.2017174075 21159647 7505956 2727394
MESH:D002471 Cell Transformation, Neoplastic Dinoprostone 20.2016192471
MESH:D002471 Cell Transformation, Neoplastic Estradiol 20.2018566989
MESH:D002493 Central Nervous System Diseases Phenobarbital 3.274080065
MESH:D018290 Cervical Intraepithelial Neoplasia Tretinoin 3.5916129372
MESH:D002637 Chest Pain Omeprazole 4.0915447763
MESH:D002659 Child Development Disorders, Pervasive Testosterone 4.5720678186
MESH:D002659 Child Development Disorders, Pervasive Valproic Acid 4.5720734317
MESH:D018281 Cholangiocarcinoma Diethylnitrosamine 6.4119052882
MESH:D018281 Cholangiocarcinoma Tetrachlorodibenzodioxin 6.4116835633
MESH:D002764 Cholecystitis Indomethacin 4.1511181007
MESH:D002779 Cholestasis 4,4'-diaminodiphenylmethane 8.739022650 19486331
MESH:D002779 Cholestasis Cyclosporine 8.7319486331
MESH:D002779 Cholestasis pirinixic acid 8.7319176532
MESH:D002822 Choriocarcinoma Tretinoin 4.1416461808
MESH:D019457 Chromosome Breakage Sodium Selenite 3.7715894690
MESH:D002972 Cleft Palate Hydrocortisone 9.5515826874
MESH:D002972 Cleft Palate Tetrachlorodibenzodioxin 9.5516354765 8697196 15668235 15340226 12621046
MESH:D002972 Cleft Palate Tretinoin 9.559407595
MESH:D002972 Cleft Palate Urethane 9.5512810352
MESH:D003092 Colitis Curcumin 14.9318200517 16804969 16782535
MESH:D003092 Colitis resveratrol 14.9316474422
MESH:D003092 Colitis Selenium 14.9317936198
MESH:D003092 Colitis Tretinoin 14.9317035595
MESH:D003103 Coloboma Curcumin 3.6318809619
MESH:D003110 Colonic Neoplasms 1,2-Dimethylhydrazine 12.1116293270 1933837 16338953 1113308 18155637
MESH:D003110 Colonic Neoplasms Curcumin 12.1119359593 16340194
MESH:D003110 Colonic Neoplasms Dexamethasone 12.1115824018
MESH:D003110 Colonic Neoplasms Genistein 12.1117182828
MESH:D003110 Colonic Neoplasms Indomethacin 12.1111260862 15625704 15637740 15786552 15963497 15936596
MESH:D003110 Colonic Neoplasms Quercetin 12.1119440933 19056647 17148506 11134977 16640504 17191121 15741050
MESH:D003110 Colonic Neoplasms resveratrol 12.1116338953
MESH:D015179 Colorectal Neoplasms arsenic trioxide 7.4620501625
MESH:D015179 Colorectal Neoplasms Cisplatin 7.4615273666
MESH:D015179 Colorectal Neoplasms Doxorubicin 7.4618259882 18802399
MESH:D015179 Colorectal Neoplasms gefitinib 7.4617594712
MESH:D015179 Colorectal Neoplasms Indomethacin 7.4618059344 12606626 17054584 11197048
MESH:D015179 Colorectal Neoplasms Quercetin 7.4618095365 18852136
MESH:D015179 Colorectal Neoplasms resveratrol 7.4616550006
MESH:D000013 Congenital Abnormalities DDT 6.5515095906
MESH:D000013 Congenital Abnormalities Tetrachlorodibenzodioxin 6.5514669216 17141729
MESH:D016510 Corneal Neovascularization Curcumin 3.9118497527
MESH:D003327 Coronary Disease Fructose 6.3218504504
MESH:D003327 Coronary Disease resveratrol 6.3216507316
MESH:D023903 Coronary Restenosis arsenic trioxide 3.2312609071
MESH:D018352 Coronavirus Infections Indomethacin 4.7017302372
MESH:D019465 Craniofacial Abnormalities arsenic trioxide 12.3510525206
MESH:D019465 Craniofacial Abnormalities Dexamethasone 12.3517728286
MESH:D019465 Craniofacial Abnormalities Hydrocortisone 12.3517728286
MESH:D019465 Craniofacial Abnormalities nitrofen 12.3511405365
MESH:D019465 Craniofacial Abnormalities Permethrin 12.3519861644
MESH:D019465 Craniofacial Abnormalities Tetrachlorodibenzodioxin 12.3520055451 10048152 15322242
MESH:D019465 Craniofacial Abnormalities Tretinoin 12.3516925845 9125849 17551590 9664655 10589399 14991402 9224671 9211117 8800419 9142499
MESH:D019465 Craniofacial Abnormalities Valproic Acid 12.358888407 17688650 16575769
MESH:D019465 Craniofacial Abnormalities Zinc 12.3519302082
MESH:D003456 Cryptorchidism Diethylstilbestrol 3.6016002989 12952375
MESH:D003490 Cyanosis 2,4-dinitrotoluene 7.6518551238
MESH:D003490 Cyanosis 2,6-dinitrotoluene 7.6518551238
MESH:D003550 Cystic Fibrosis Acetylcysteine 6.2719747007
MESH:D003550 Cystic Fibrosis Glutathione 6.2719747007
MESH:D016757 Death, Sudden, Cardiac arsenic trioxide 3.1615213294
MESH:D003711 Demyelinating Diseases Tamoxifen 3.3819031437
MESH:D017449 Dermatitis, Allergic Contact 4,4'-diaminodiphenylmethane 3.978156756 11906362 12868966 2524372 18759878 14531868 11298694 8970840
MESH:D017449 Dermatitis, Allergic Contact Dexamethasone 3.9712438553
MESH:D003876 Dermatitis, Atopic pirinixic acid 1.8518249437
MESH:D003877 Dermatitis, Contact 4,4'-diaminodiphenylmethane 6.583621924 2952479
MESH:D003877 Dermatitis, Contact Permethrin 6.5814617103
MESH:D003920 Diabetes Mellitus rosiglitazone 10.4717446233
MESH:D003920 Diabetes Mellitus Sodium Selenite 10.4716285004
MESH:D003920 Diabetes Mellitus Zinc 10.4716479319
MESH:D003921 Diabetes Mellitus, Experimental Fructose 9.1918603373
MESH:D003921 Diabetes Mellitus, Experimental Quercetin 9.1919496084
MESH:D003921 Diabetes Mellitus, Experimental resveratrol 9.1916873680
MESH:D003924 Diabetes Mellitus, Type 2 Curcumin 14.8018403477
MESH:D003924 Diabetes Mellitus, Type 2 Diethylnitrosamine 14.8020387270
MESH:D003924 Diabetes Mellitus, Type 2 epigallocatechin gallate 14.8016988119
MESH:D003924 Diabetes Mellitus, Type 2 Fructose 14.8018603373
MESH:D003924 Diabetes Mellitus, Type 2 Genistein 14.8016647724
MESH:D003924 Diabetes Mellitus, Type 2 rosiglitazone 14.8012642470
MESH:D003924 Diabetes Mellitus, Type 2 Tetrachlorodibenzodioxin 14.8017107852
MESH:D003928 Diabetic Nephropathies Curcumin 18.9018204486
MESH:D003928 Diabetic Nephropathies Estradiol 18.9019279558
MESH:D003928 Diabetic Nephropathies Plant Extracts 18.9019706694
MESH:D003928 Diabetic Nephropathies resveratrol 18.9016286809
MESH:D003928 Diabetic Nephropathies Tamoxifen 18.9019279558
MESH:D003929 Diabetic Neuropathies Progesterone 3.5117187935
MESH:D003967 Diarrhea Dexamethasone 11.377237001
MESH:D003967 Diarrhea Dinoprostone 11.3711488427 7237001 10446763
MESH:D003967 Diarrhea Hydrocortisone 11.377237001
MESH:D003967 Diarrhea Indomethacin 11.377237001 7907874
MESH:D056486 Drug-Induced Liver Injury 2,4-dinitrotoluene 31.5421346803 18551238
MESH:D056486 Drug-Induced Liver Injury 2,6-dinitrotoluene 31.5418551238 21346803
MESH:D056486 Drug-Induced Liver Injury 4,4'-diaminodiphenylmethane 31.547440962 6482804 18289764 9653073 18692083 9328219 9022650 16192314 11289319 6679447 8291058 1440618 18648102
MESH:D056486 Drug-Induced Liver Injury Acetaminophen 31.5412392966 11287661 16393943 16177239 19370779 15968718 17562736 10915739 12594235 12958197 16485898 19085960 18713872 2444490 19164858 16081117 19420014 19923254 12153990 16781746 10663392 15619225 10774834 17522070 11529661 19739265 11739529 16227642 18071297 11834606 11461765 14986274 11743745 17906064 12540782 16109766 14550746 11421492 19416960 14725611 12705907
MESH:D056486 Drug-Induced Liver Injury Acetylcysteine 31.5411287661
MESH:D056486 Drug-Induced Liver Injury Carbon Tetrachloride 31.547120509 15968718 7440962 2869522 19336974 16177239 3786805 21278145 15027814 19085960 7179309 17522070 11566570 6884620 3732212 10915739 6623471 10092053 15998439 4309450 16227642 9327722
MESH:D056486 Drug-Induced Liver Injury Diethylnitrosamine 31.5419107877
MESH:D056486 Drug-Induced Liver Injury Dimethylnitrosamine 31.548172417
MESH:D056486 Drug-Induced Liver Injury Doxorubicin 31.5417416283
MESH:D056486 Drug-Induced Liver Injury Nevirapine 31.5414986274
MESH:D056486 Drug-Induced Liver Injury Selenium 31.5415131321
MESH:D056486 Drug-Induced Liver Injury Sodium Selenite 31.5415131321
MESH:D056486 Drug-Induced Liver Injury Tetrachlorodibenzodioxin 31.5420420201
MESH:D056486 Drug-Induced Liver Injury Valproic Acid 31.541733752 19641884
MESH:D056487 Drug-Induced Liver Injury, Chronic Acetaminophen 3.0819426721
MESH:D004362 Drug Toxicity Cisplatin 13.0912231392 19839026 15033597 12649298
MESH:D004362 Drug Toxicity Doxorubicin 13.0918602426
MESH:D004362 Drug Toxicity Gentamicins 13.0915033597 11033412
MESH:D004362 Drug Toxicity Tetrachlorodibenzodioxin 13.0911462148
MESH:D004374 Ductus Arteriosus, Patent Ibuprofen 9.9118450898 18446180 16133044
MESH:D004374 Ductus Arteriosus, Patent Indomethacin 9.9112774134 18446180 16133044 17190690 18043480 16326151
MESH:D004381 Duodenal Ulcer Curcumin 9.9817351913
MESH:D004381 Duodenal Ulcer Indomethacin 9.9817151854 11595415 17045617 17202747 17329845 10671773 11535926 11595431 17351913 16699067 11991626
MESH:D004381 Duodenal Ulcer Omeprazole 9.9816613094 17151854 21218061 15991576
MESH:D004417 Dyspnea DDT 4.1616487989
MESH:D004421 Dystonia Phenobarbital 7.321851702
MESH:D004421 Dystonia Valproic Acid 7.321851702
MESH:D004485 Eczema Dexamethasone 3.5012438553
MESH:D004487 Edema Dexamethasone 34.3319703484
MESH:D004487 Edema Indomethacin 34.338273558 7907874 8985016 16100529 10653021 7990266 19703484
MESH:D004487 Edema Mustard Gas 34.3311402378 9260866 11428631 11428647
MESH:D004487 Edema perfluorooctanoic acid 34.3317259670 12083418
MESH:D004487 Edema pirinixic acid 34.3312083418
MESH:D004487 Edema Plant Extracts 34.3312787963
MESH:D004487 Edema resveratrol 34.338985016
MESH:D004487 Edema rosiglitazone 34.3312083418
MESH:D004487 Edema Sodium Salicylate 34.3310653021
MESH:D004487 Edema Staurosporine 34.338273558
MESH:D004487 Edema Tetrachlorodibenzodioxin 34.3312711302 11000095
MESH:D004489 Edema, Cardiac Tetrachlorodibenzodioxin 8.5715322242 16714409 18230668
MESH:D004489 Edema, Cardiac Tretinoin 8.5718230668
MESH:D004681 Encephalomyelitis, Autoimmune, Experimental Calcitriol 14.2115138306
MESH:D004681 Encephalomyelitis, Autoimmune, Experimental Progesterone 14.2117692515
MESH:D004681 Encephalomyelitis, Autoimmune, Experimental resveratrol 14.2117872969
MESH:D004681 Encephalomyelitis, Autoimmune, Experimental Tamoxifen 14.2119031437
MESH:D004714 Endometrial Hyperplasia Diethylstilbestrol 8.5816402032
MESH:D004714 Endometrial Hyperplasia Genistein 8.5816402032
MESH:D016889 Endometrial Neoplasms 4-hydroxytamoxifen 23.7819148513
MESH:D016889 Endometrial Neoplasms Diethylstilbestrol 23.7815700306 16804899
MESH:D016889 Endometrial Neoplasms Doxorubicin 23.7817359293
MESH:D016889 Endometrial Neoplasms Estradiol 23.7818566989 11473722 19148513
MESH:D016889 Endometrial Neoplasms Genistein 23.7811473722
MESH:D016889 Endometrial Neoplasms Tamoxifen 23.7817893378 20544844 16202921 19155303
MESH:D016889 Endometrial Neoplasms Tretinoin 23.7816569247
MESH:D004715 Endometriosis Ibuprofen 19.2415652904
MESH:D004715 Endometriosis Indomethacin 19.2415652904
MESH:D004715 Endometriosis Mifepristone 19.2416134523
MESH:D004715 Endometriosis Progesterone 19.2416134523
MESH:D004715 Endometriosis Tetrachlorodibenzodioxin 19.2410568697 9294722
MESH:D004719 Endomyocardial Fibrosis Doxorubicin 10.6818037988
MESH:D004719 Endomyocardial Fibrosis Plant Extracts 10.6815268973
MESH:D019446 Endotoxemia Ibuprofen 7.5611545620
MESH:D019446 Endotoxemia Indomethacin 7.5618509659
MESH:D004751 Enteritis Indomethacin 3.7310567023 17763956 16328016
MESH:D020345 Enterocolitis, Necrotizing Indomethacin 9.1217980183
MESH:D020345 Enterocolitis, Necrotizing resveratrol 9.1217923197
MESH:D004802 Eosinophilia Indomethacin 3.1011298111
MESH:D004831 Epilepsies, Myoclonic Phenobarbital 7.553659116
MESH:D004831 Epilepsies, Myoclonic Valproic Acid 7.5517275665 3659116
MESH:D004828 Epilepsies, Partial Phenobarbital 6.633922381 11558140
MESH:D004828 Epilepsies, Partial Valproic Acid 6.633922381 16628512
MESH:D004827 Epilepsy Norepinephrine 10.56821787
MESH:D004827 Epilepsy Phenobarbital 10.5620417680
MESH:D004827 Epilepsy Plant Extracts 10.5619439326 19700373
MESH:D004827 Epilepsy Valproic Acid 10.5618234410 20417680
MESH:D004832 Epilepsy, Absence Phenobarbital 5.966401628
MESH:D004832 Epilepsy, Absence Valproic Acid 5.966254150 7562514 6426943
MESH:D017029 Epilepsy, Complex Partial Phenobarbital 8.057750514
MESH:D017029 Epilepsy, Complex Partial Valproic Acid 8.057750514
MESH:D004830 Epilepsy, Tonic-Clonic Phenobarbital 7.183659116
MESH:D004830 Epilepsy, Tonic-Clonic Valproic Acid 7.183659116
MESH:D004890 Erythema Mustard Gas 4.169357497
MESH:D004931 Esophageal Achalasia Diethylnitrosamine 4.1016302075
MESH:D004938 Esophageal Neoplasms 4,4'-diaminodiphenylmethane 12.083581430
MESH:D004938 Esophageal Neoplasms arsenic trioxide 12.0812903497
MESH:D004938 Esophageal Neoplasms Cisplatin 12.0816481741 17638652 15464296 16785472 15173087
MESH:D004938 Esophageal Neoplasms Dimethylnitrosamine 12.0817016578
MESH:D004938 Esophageal Neoplasms Indomethacin 12.0811005569
MESH:D004938 Esophageal Neoplasms Zinc 12.0816543248
MESH:D005124 Eye Abnormalities Tetrachlorodibenzodioxin 6.1411564622
MESH:D005124 Eye Abnormalities Tretinoin 6.1416938888 9664655
MESH:D005234 Fatty Liver arsenic trioxide 41.3915073043
MESH:D005234 Fatty Liver Carbon Tetrachloride 41.3912631006 16045604 61145 17595544 15959796 16239168 12795759 19224547
MESH:D005234 Fatty Liver Curcumin 41.3919297423
MESH:D005234 Fatty Liver Cyclosporine 41.3919224547
MESH:D005234 Fatty Liver Diethylnitrosamine 41.3920387270 21071580
MESH:D005234 Fatty Liver Fructose 41.3918395287 19196556 18641190
MESH:D005234 Fatty Liver pirinixic acid 41.3919236843 20131406
MESH:D005234 Fatty Liver Plant Extracts 41.3915975614
MESH:D005234 Fatty Liver rosiglitazone 41.3919196556
MESH:D005234 Fatty Liver Tamoxifen 41.3919224547 14986274
MESH:D005234 Fatty Liver Valproic Acid 41.3914986274 19224547
MESH:D052776 Female Urogenital Diseases Diethylstilbestrol 5.8316002989 16513791 16534752 16611131 15751030
MESH:D052776 Female Urogenital Diseases Tamoxifen 5.8316709447
MESH:D005313 Fetal Death Tetrachlorodibenzodioxin 2.4811858732
MESH:D005315 Fetal Diseases Valproic Acid 3.8716575769
MESH:D005317 Fetal Growth Retardation Valproic Acid 3.178888407 18558336
MESH:D005334 Fever Dinoprostone 10.3616997862 11852909
MESH:D005334 Fever Ibuprofen 10.3616997862
MESH:D005334 Fever Indomethacin 10.3610431976 17627676 11852909
MESH:D005350 Fibroma 4,4'-diaminodiphenylmethane 4.006705139
MESH:D018221 Fibromatosis, Abdominal Tamoxifen 3.5314745880
MESH:D018222 Fibromatosis, Aggressive Doxorubicin 8.1319069698
MESH:D018222 Fibromatosis, Aggressive Tamoxifen 8.1319069698
MESH:D005354 Fibrosarcoma Indomethacin 3.8910962813
MESH:D005355 Fibrosis Carbon Tetrachloride 31.7318705752
MESH:D005355 Fibrosis Curcumin 31.7318705752
MESH:D005355 Fibrosis Cyclosporine 31.7312168785 12639820
MESH:D005355 Fibrosis Fructose 31.7318504504
MESH:D005355 Fibrosis Indomethacin 31.7317994277
MESH:D005355 Fibrosis Quercetin 31.7319474275
MESH:D005355 Fibrosis Tetrachlorodibenzodioxin 31.7320067830
MESH:D005355 Fibrosis Tretinoin 31.7317994277
MESH:D005391 Firesetting Behavior Testosterone 4.847506515
MESH:D005499 Folliculitis Indomethacin 4.1511298111
MESH:D005532 Foot Deformities, Congenital methoxyacetic acid 4.763652986
MESH:D005706 Gallbladder Neoplasms arsenic trioxide 3.3016904648
MESH:D005756 Gastritis Acetaminophen 13.2416983495
MESH:D005756 Gastritis Indomethacin 13.2415046732
MESH:D005756 Gastritis Zinc 13.2417241300
MESH:D005770 Gastrointestinal Neoplasms Curcumin 3.7118462866
MESH:D020022 Genetic Predisposition to Disease marker/mechanism 14514962
MESH:D005833 Genital Neoplasms, Female Diethylstilbestrol 3.9516452187
MESH:D005885 Gingival Hyperplasia Cyclosporine 3.228708960
MESH:D005909 Glioblastoma marker/mechanism 16598420
MESH:D005909 Glioblastoma Curcumin 26.3517596214
MESH:D005909 Glioblastoma Doxorubicin 26.3517150277
MESH:D005909 Glioblastoma Genistein 26.3516598420
MESH:D005909 Glioblastoma Indomethacin 26.3512870263
MESH:D005909 Glioblastoma myricetin 26.3519804834
MESH:D005909 Glioblastoma Quercetin 26.3519804834
MESH:D005909 Glioblastoma Testosterone 26.3517162496
MESH:D005909 Glioblastoma Tretinoin 26.3517312396
MESH:D005910 Glioma Indomethacin 4.5216487511 18371953
MESH:D005910 Glioma Quercetin 4.5217643826
MESH:D005923 Glomerulosclerosis, Focal Segmental Indomethacin 3.4411849393
MESH:D018149 Glucose Intolerance Fructose 4.3819165636
MESH:D006042 Goiter 4,4'-diaminodiphenylmethane 3.107505956
MESH:D006058 Gonadal Disorders Tetrachlorodibenzodioxin 3.5710696789
MESH:D006073 Gout Indomethacin 4.3511248219
MESH:D006130 Growth Disorders Zinc 3.2317217573
MESH:D006258 Head and Neck Neoplasms Cisplatin 20.4115464296 15102660
MESH:D006258 Head and Neck Neoplasms Curcumin 20.4118462866 18829502
MESH:D006258 Head and Neck Neoplasms Doxorubicin 20.4115692506
MESH:D006258 Head and Neck Neoplasms Indomethacin 20.4115482327
MESH:D006258 Head and Neck Neoplasms Sirolimus 20.4119435901
MESH:D006258 Head and Neck Neoplasms Tretinoin 20.4116096774
MESH:D034381 Hearing Loss Cisplatin 7.3719898482
MESH:D034381 Hearing Loss Gentamicins 7.3717868369 18024279 19130971 15968427
MESH:D006317 Hearing Loss, Noise-Induced Tretinoin 4.1416084493
MESH:D006319 Hearing Loss, Sensorineural Cisplatin 3.5515464296
MESH:D006330 Heart Defects, Congenital nitrofen 7.5216080930
MESH:D006330 Heart Defects, Congenital Tetrachlorodibenzodioxin 7.5211294989 10048152
MESH:D006330 Heart Defects, Congenital Tretinoin 7.529664655 14991402
MESH:D006331 Heart Diseases Doxorubicin 5.5518674790 12587719 18006777 16244371 14766674 17888722 17875725 16330681 16495754 16144979 16244372 16879835 16707910
MESH:D006331 Heart Diseases Urethane 5.5516046796
MESH:D006333 Heart Failure Doxorubicin 14.6317481944
MESH:D006333 Heart Failure pirinixic acid 14.6320558911
MESH:D006333 Heart Failure Plant Extracts 14.6318097624
MESH:D006333 Heart Failure Selenium 14.6317162251
MESH:D006333 Heart Failure Zinc 14.6317162251
MESH:D006335 Heart Injuries Zinc 4.7517074742
MESH:D016481 Helicobacter Infections Zinc 3.6017241300
MESH:D006390 Hemangioendothelioma 2-Acetylaminofluorene 4.306705139
MESH:D006394 Hemangiosarcoma 2-Acetylaminofluorene 6.396705139
MESH:D006394 Hemangiosarcoma Doxorubicin 6.3915692506
MESH:D006457 Hemoglobinuria, Paroxysmal Cyclosporine 3.4215720958
MESH:D006470 Hemorrhage Tetrachlorodibenzodioxin 2.4211000095
MESH:D006501 Hepatic Encephalopathy Indomethacin 3.6515633222
MESH:D006505 Hepatitis 4,4'-diaminodiphenylmethane 10.336705139
MESH:D006505 Hepatitis Carbon Tetrachloride 10.3319900420 19110552
MESH:D006505 Hepatitis DDT 10.3316487989
MESH:D019698 Hepatitis C, Chronic Indomethacin 3.7215135802
MESH:D006527 Hepatolenticular Degeneration Zinc 3.7117276780
MESH:D006529 Hepatomegaly DDT 16.992387028
MESH:D006529 Hepatomegaly perfluorooctanoic acid 16.993609246
MESH:D006529 Hepatomegaly Phenobarbital 16.9916109766
MESH:D006529 Hepatomegaly pirinixic acid 16.9919772884 16221962 19176532 18467677
MESH:D006529 Hepatomegaly Tetrachlorodibenzodioxin 16.9915340226 12621046 16120746
MESH:D015417 Hereditary Sensory and Motor Neuropathy Curcumin 4.0617701891
MESH:D006548 Hernia, Diaphragmatic Dexamethasone 4.777520565
MESH:D006548 Hernia, Diaphragmatic nitrofen 4.7710370017 10898222 15793718 17270546 12021965 9473106 8863223 10898224 16490937 16080930 12194112 16473863 10693666 16292651 12505043 15764645 9698600 9575882 15136996 12746050 12407540 17618886 7760232 18280291 10370016 7576705 17245593 10541330 11076806 9476886 11329586 7520565 18280292 11588001 15185205 16863852 11057544 15707848 15088113 12759764 11584395 10359170 15578192 12904592 15756563 11051153 9859898 11409163 16720372 18958481 10646786 12547725 11685700
MESH:D006558 Herpes Genitalis Estradiol 4.0115709030
MESH:D006561 Herpes Simplex Amsacrine 15.3710809021
MESH:D006561 Herpes Simplex Etoposide 15.3710809021
MESH:D006561 Herpes Simplex Plant Extracts 15.3710715843
MESH:D006561 Herpes Simplex resveratrol 15.3716876885
MESH:D006628 Hirsutism Testosterone 4.6317019078
MESH:D015658 HIV Infections Nevirapine 5.4111141242
MESH:D015658 HIV Infections Plant Extracts 5.4112878215
MESH:D006689 Hodgkin Disease Cisplatin 7.4716170182 16200630
MESH:D006689 Hodgkin Disease Doxorubicin 7.4715147373 18501091 17606976
MESH:D006689 Hodgkin Disease Etoposide 7.4718180244 16135485 16200630 17606976 15147373
MESH:D019584 Hot Flashes Estradiol 6.9917088409
MESH:D019584 Hot Flashes Plant Extracts 6.9914716179 16566672 17454163
MESH:D006849 Hydrocephalus Valproic Acid 3.8617688650
MESH:D006869 Hydronephrosis Tetrachlorodibenzodioxin 3.0315340226 18606429 8697196 16959395 16354765
MESH:D006930 Hyperalgesia Acetaminophen 24.0816870215
MESH:D006930 Hyperalgesia Dinoprostone 24.0816793879
MESH:D006930 Hyperalgesia Freund's Adjuvant 24.0816769263
MESH:D006930 Hyperalgesia Indomethacin 24.0812727271
MESH:D006930 Hyperalgesia perfluorooctanoic acid 24.0812083418
MESH:D006930 Hyperalgesia rosiglitazone 24.0812083418
MESH:D006930 Hyperalgesia Tretinoin 24.0816870215
MESH:D034321 Hyperamylasemia Indomethacin 4.7017883296
MESH:D017588 Hyperandrogenism Testosterone 4.2917019078
MESH:D006932 Hyperbilirubinemia Carbon Tetrachloride 3.5316899240
MESH:D053565 Hypercalciuria Gentamicins 4.7017652376
MESH:D006937 Hypercholesterolemia Curcumin 6.3618704882
MESH:D006937 Hypercholesterolemia resveratrol 6.3617188708
MESH:D006940 Hyperemia Indomethacin 4.0012524144
MESH:D017681 Hypereosinophilic Syndrome Tretinoin 3.5816778211
MESH:D006943 Hyperglycemia pirinixic acid 6.2720558911
MESH:D006943 Hyperglycemia Quercetin 6.2711834736 18262572
MESH:D020138 Hyperhomocysteinemia Plant Extracts 3.5916484555
MESH:D006946 Hyperinsulinism Fructose 4.0319008412 18563319 14757778 15752949 18360027
MESH:D006949 Hyperlipidemias Fructose 14.5015752949
MESH:D006949 Hyperlipidemias Indomethacin 14.5017546600
MESH:D006949 Hyperlipidemias Plant Extracts 14.5015268973 15975614
MESH:D006949 Hyperlipidemias resveratrol 14.5016873680
MESH:D006965 Hyperplasia 4,4'-diaminodiphenylmethane 7.5915034207
MESH:D006965 Hyperplasia Diethylstilbestrol 7.5912960047 14722030
MESH:D006973 Hypertension Cyclosporine 16.8910903974
MESH:D006973 Hypertension Desoxycorticosterone 16.8911507004 19564549
MESH:D006973 Hypertension Dexamethasone 16.8917042910
MESH:D006973 Hypertension Fructose 16.8919008412 14633139 14568997 14573337 16843071
MESH:D006973 Hypertension Phenylephrine 16.8912717712 8949925
MESH:D006973 Hypertension Quercetin 16.8918356687
MESH:D006973 Hypertension Tetrachlorodibenzodioxin 16.8918850075 18670907
MESH:D006975 Hypertension, Portal Carbon Tetrachloride 3.1115338365
MESH:D006976 Hypertension, Pulmonary gefitinib 3.9218424623
MESH:D015228 Hypertriglyceridemia Fructose 4.1819342510 19799862
MESH:D006984 Hypertrophy Ibuprofen 12.6216672835
MESH:D006984 Hypertrophy Phenylephrine 12.6212791704 18502941
MESH:D006984 Hypertrophy Sirolimus 12.6219211884
MESH:D017379 Hypertrophy, Left Ventricular resveratrol 3.4017488730
MESH:D017380 Hypertrophy, Right Ventricular gefitinib 5.2318424623
MESH:D007006 Hypogonadism Testosterone 3.8012002444
OMIM:611718 HYPOMAGNESEMIA 4, RENAL marker/mechanism
MESH:D007018 Hypopituitarism Testosterone 5.1817426086
MESH:D007021 Hypospadias Diethylstilbestrol 3.6016002989
MESH:D007022 Hypotension Norepinephrine 4.076740701
MESH:D007077 Ileal Diseases 1-Methyl-3-isobutylxanthine 9.3518306037
MESH:D007077 Ileal Diseases Indomethacin 9.3510574470 18306037
MESH:D007079 Ileitis Indomethacin 4.3516133968 10651667 10647630
MESH:D007174 Impulse Control Disorders Testosterone 4.847506515
MESH:D007235 Infant, Premature, Diseases Ibuprofen 10.8216133044
MESH:D007235 Infant, Premature, Diseases Indomethacin 10.8216133044
MESH:D020244 Infarction, Middle Cerebral Artery Progesterone 8.2415869954
MESH:D020244 Infarction, Middle Cerebral Artery resveratrol 8.2417600658
MESH:D007246 Infertility Diethylstilbestrol 3.4015036965
MESH:D007248 Infertility, Male DDT 5.0817157474 17192596
MESH:D007248 Infertility, Male fulvestrant 5.0811514358
MESH:D007249 Inflammation Curcumin 41.0316956363 18403477 17151092
MESH:D007249 Inflammation Dexamethasone 41.038960868 11099482
MESH:D007249 Inflammation Diethylnitrosamine 41.0318785209
MESH:D007249 Inflammation Flurbiprofen 41.0311099482
MESH:D007249 Inflammation Freund's Adjuvant 41.0316793879
MESH:D007249 Inflammation Ibuprofen 41.033291741
MESH:D007249 Inflammation Indomethacin 41.0312568917 3291741 7812673
MESH:D007249 Inflammation Mustard Gas 41.0317524151 11402378 9260866 11428647 8975870 11428620 16001271 9357497 11428631
MESH:D007249 Inflammation perfluorooctanoic acid 41.0312083418
MESH:D007249 Inflammation Plant Extracts 41.0315997105 12787963 19332304 16366677
MESH:D007249 Inflammation Progesterone 41.0315869954
MESH:D007249 Inflammation resveratrol 41.0316366677
MESH:D007249 Inflammation rosiglitazone 41.0312083418
MESH:D007249 Inflammation Tamoxifen 41.0319457130
MESH:D007249 Inflammation Tetrachlorodibenzodioxin 41.0312878042 12200463
MESH:D015212 Inflammatory Bowel Diseases Curcumin 2.6918200517 18596194
MESH:D007251 Influenza, Human pyrrolidine dithiocarbamic acid 18.4618473937
MESH:D007251 Influenza, Human Quercetin 18.4616624496
MESH:D007251 Influenza, Human resveratrol 18.4616624496
MESH:D007251 Influenza, Human Selenium 18.4616624496
MESH:D007299 Insect Bites and Stings Permethrin 4.8112749493 15189238 12971516
MESH:D007333 Insulin Resistance Estradiol 15.3816627594 16393666
MESH:D007333 Insulin Resistance Fructose 15.3819799862 14757778 19008412 19342510 14573337 18981581 14633139 17133782 19586609 18057795 18563319
MESH:D007333 Insulin Resistance pirinixic acid 15.3816306350
MESH:D007333 Insulin Resistance rosiglitazone 15.3816306350
MESH:D007333 Insulin Resistance Sodium Selenite 15.3814714311
MESH:D007410 Intestinal Diseases Indomethacin 6.6617329856 11686837 18236018 11855677 17994277 15831440 10210152 11713966 15610444
MESH:D007410 Intestinal Diseases Tretinoin 6.6617994277
MESH:D007414 Intestinal Neoplasms Curcumin 7.1310783313
MESH:D007414 Intestinal Neoplasms Plant Extracts 7.1312351151 12584176 12628509
MESH:D019586 Intracranial Hypertension Indomethacin 4.3515241188
MESH:D007511 Ischemia Zinc 3.6616584753
MESH:D007565 Jaundice 4,4'-diaminodiphenylmethane 4.008074119 9022650
MESH:D007569 Jaw Abnormalities Tetrachlorodibenzodioxin 6.8916580747
MESH:D007569 Jaw Abnormalities Tretinoin 6.8917551590 15992940
MESH:D007579 Jejunal Diseases 1-Methyl-3-isobutylxanthine 9.3518306037
MESH:D007579 Jejunal Diseases Indomethacin 9.3510574470 16133968 18306037
MESH:D007627 Keloid Quercetin 3.9717086741
MESH:D007638 Keratoconjunctivitis Sicca Cyclosporine 3.4215604871
MESH:D007673 Kidney Cortex Necrosis Cisplatin 9.9515464296
MESH:D007673 Kidney Cortex Necrosis Gentamicins 9.9518842672
MESH:D007674 Kidney Diseases Acetaminophen 33.4015629191 12587719
MESH:D007674 Kidney Diseases Bacitracin 33.4018289764
MESH:D007674 Kidney Diseases Cisplatin 33.4012649298 15190930 19839026 18289764 12231392
MESH:D007674 Kidney Diseases Cyclosporine 33.408314463 18776723 10903974
MESH:D007674 Kidney Diseases Doxorubicin 33.4015369732 15699352 16775033
MESH:D007674 Kidney Diseases Estradiol 33.4015618244
MESH:D007674 Kidney Diseases Gentamicins 33.4019349640 18289764 17934191
MESH:D007674 Kidney Diseases Indomethacin 33.4017190690
MESH:D007674 Kidney Diseases Quercetin 33.4016962696
MESH:D007674 Kidney Diseases Vancomycin 33.4018289764
MESH:D007674 Kidney Diseases Zinc 33.4016960431
MESH:D007676 Kidney Failure, Chronic Doxorubicin 16.3816707910
MESH:D007676 Kidney Failure, Chronic Hydrogen Peroxide 16.3816518626
MESH:D007676 Kidney Failure, Chronic Selenium 16.3816518626
MESH:D007676 Kidney Failure, Chronic Zinc 16.3816518626
MESH:D007680 Kidney Neoplasms 2,4-dinitrotoluene 26.3416705839
MESH:D007680 Kidney Neoplasms 2,6-dinitrotoluene 26.3416705839
MESH:D007680 Kidney Neoplasms 4,4'-diaminodiphenylmethane 26.346582329
MESH:D007680 Kidney Neoplasms Cyclosporine 26.3412371664
MESH:D007680 Kidney Neoplasms Diethylstilbestrol 26.3416762066 15003126 14681315
MESH:D007680 Kidney Neoplasms Estradiol 26.3415610895
MESH:D007680 Kidney Neoplasms gefitinib 26.3418625569
MESH:D007680 Kidney Neoplasms Tamoxifen 26.3418625569
MESH:D007683 Kidney Tubular Necrosis, Acute Calcium 13.9916316344
MESH:D007683 Kidney Tubular Necrosis, Acute Cisplatin 13.9911231351
MESH:D007683 Kidney Tubular Necrosis, Acute Gentamicins 13.9911231351
MESH:D007859 Learning Disorders DDT 6.857589230
MESH:D007859 Learning Disorders Diethylstilbestrol 6.8517184923
MESH:D007889 Leiomyoma Curcumin 3.6318555241
MESH:D016773 Leishmaniasis, Cutaneous Gentamicins 9.2510219319
MESH:D016773 Leishmaniasis, Cutaneous Indomethacin 9.2511703811 12228301 10320625
MESH:D016773 Leishmaniasis, Cutaneous Omeprazole 9.2519248655
MESH:D007938 Leukemia 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 20.1812970779
MESH:D007938 Leukemia arsenic trioxide 20.1815070760
MESH:D007938 Leukemia Curcumin 20.1818462866
MESH:D007938 Leukemia Genistein 20.1817468513 18980019
MESH:D007938 Leukemia Permethrin 20.1812937054
MESH:D007938 Leukemia Quercetin 20.1817468513
MESH:D007938 Leukemia Tretinoin 20.1817143497
MESH:D004915 Leukemia, Erythroblastic, Acute Doxorubicin 4.1416085563
MESH:D015459 Leukemia-Lymphoma, Adult T-Cell arsenic trioxide 6.7312560223 17077332
MESH:D015459 Leukemia-Lymphoma, Adult T-Cell Curcumin 6.7316106398
MESH:D007948 Leukemia, Monocytic, Acute anthra(1,9-cd)pyrazol-6(2H)-one 19.9816972261
MESH:D007948 Leukemia, Monocytic, Acute arsenic trioxide 19.9816972261
MESH:D007948 Leukemia, Monocytic, Acute PD 98059 19.9816972261
MESH:D007948 Leukemia, Monocytic, Acute U 0126 19.9816972261
MESH:D015464 Leukemia, Myelogenous, Chronic, BCR-ABL Positive arsenic trioxide 5.8814633726
MESH:D015464 Leukemia, Myelogenous, Chronic, BCR-ABL Positive Indomethacin 5.8816572323 10785260 15631656
MESH:D007951 Leukemia, Myeloid arsenic trioxide 6.4419077051
MESH:D007951 Leukemia, Myeloid Tretinoin 6.4416482212 16932348 19285840
MESH:D015470 Leukemia, Myeloid, Acute Amsacrine 8.2118043129 15148258
MESH:D015470 Leukemia, Myeloid, Acute arsenic trioxide 8.2116467208 20471514 19850784 16968895 17050201
MESH:D015470 Leukemia, Myeloid, Acute Indomethacin 8.2118360721
MESH:D015470 Leukemia, Myeloid, Acute Tretinoin 8.2116294345 17596541 19850784
MESH:D015470 Leukemia, Myeloid, Acute Valproic Acid 8.2117596541 16294345
MESH:D015473 Leukemia, Promyelocytic, Acute arsenic trioxide 8.4716330433 17712046 17217047 9834237 11161223 11468182 15336539 19075265 15748426 17107899 16331271 16112521 15622746 12712474 19225113 19035177 17869043 19642359 12679006 12018890 16966277 16891316 15213294 16823087 17649720
MESH:D015473 Leukemia, Promyelocytic, Acute resveratrol 8.4716087638
MESH:D015473 Leukemia, Promyelocytic, Acute Tretinoin 8.4717107899 19029980 17339181 17506722 16891316 12679006 17649720 19225113 19035177 17294898 19075265 17361223 9834237 16823087 19642359 15748426 16788101 16766008 17712046 17301526 17368321 17217047 16935935 16331271 16140955
MESH:D015458 Leukemia, T-Cell arsenic trioxide 8.5316882451
MESH:D015458 Leukemia, T-Cell Curcumin 8.5316106398
MESH:D007964 Leukocytosis Indomethacin 4.3516537180
MESH:D007969 Leukomalacia, Periventricular Indomethacin 4.7017980183
MESH:D007984 Leydig Cell Tumor perfluorooctanoic acid 4.238812269
MESH:D017880 Limb Deformities, Congenital methoxyacetic acid 6.0412805644 15959878
MESH:D017880 Limb Deformities, Congenital Tretinoin 6.049224671
MESH:D008064 Lipidoses Tamoxifen 2.3817567588 15342952
MESH:D008101 Liver Abscess, Amebic Indomethacin 4.7011479899
MESH:D008103 Liver Cirrhosis Carbon Tetrachloride 10.3011903743 11408273 17334410 16943688 21278145 16221502 17157831 17174718 16239168
MESH:D008103 Liver Cirrhosis Diethylnitrosamine 10.3018522880 19638242 20032147 18407596 18665156
MESH:D008103 Liver Cirrhosis Phenobarbital 10.3021047994
MESH:D008103 Liver Cirrhosis Plant Extracts 10.3017157831
MESH:D008105 Liver Cirrhosis, Biliary 4,4'-diaminodiphenylmethane 2.4815034207 9327722
MESH:D008106 Liver Cirrhosis, Experimental Carbon Tetrachloride 34.3512445418 17766677 18472332 16011737 17823541 18705752 12666154 12586293 15370692 20821823 14512876 15650968 15730626 14724832 14716496 18205269 18006644 17976157 17481882 17721639 18210741 18420326 16248980 18339082 18472094 13678700 15925388 17922224 15673190 17944888 18277467 18395095 14620537 12609069 17869086 12958196 12389079 15052691 17698563 11481614 12649538 14716833 12632514 18263696 15818738 10355542 16136751 15362042 17761835 15931870 14748882 15996030 18054572 15123356 15338365 15893842 17805973 12632512 16015684 18279442 17708605 17900296 12445421 18481824 18429990 16116963 18412020 18187930 18156304 18317297 17525996 16638106 18418968 12741479 17557913 18166357 12898905 17565644 12546737 15057751 18251166 16033810 15876570 16097048 18376398 17631135 12667390 15959796 16027843 16192424 17714472 18395914 17640975
MESH:D008106 Liver Cirrhosis, Experimental Curcumin 34.3518705752 17355460 18006644
MESH:D008106 Liver Cirrhosis, Experimental Dexamethasone 34.3516718785
MESH:D008106 Liver Cirrhosis, Experimental Dimethylnitrosamine 34.3516544323 14568256 17432682 15161499 15763062 15383259 15298665 15798949 17640959 15369754 17348192 15571005 14659978 14643895 18672772 17201889 18095165 15591649 17881167 18637143 15081153 15793283 15067225 18629640 12925901 16570917 15086199 17534399 15339415 15744066 18237412 15504291 16042886 15842777 15864749 18567088 15942678 16603200 15138612 15366600 18364076 17203207 17036385 16627068 17666798 17724770 15492853 15577212 17196135 16009107 18210741 15723089 16270385 14726149 14709902 12918455 17465448 15733078 16169303 18371158 15479170 17198567 17719030 18239293 15099470
MESH:D008106 Liver Cirrhosis, Experimental Dinoprostone 34.3515816358
MESH:D008106 Liver Cirrhosis, Experimental Doxorubicin 34.3516595196 16439617
MESH:D008106 Liver Cirrhosis, Experimental epigallocatechin gallate 34.3517481882
MESH:D008106 Liver Cirrhosis, Experimental Estradiol 34.3514716833 14659978
MESH:D008106 Liver Cirrhosis, Experimental Genistein 34.3517823541
MESH:D008106 Liver Cirrhosis, Experimental Indomethacin 34.3518194892
MESH:D008106 Liver Cirrhosis, Experimental pirinixic acid 34.3515474484
MESH:D008106 Liver Cirrhosis, Experimental Plant Extracts 34.3515479170
MESH:D008106 Liver Cirrhosis, Experimental pyrrolidine dithiocarbamic acid 34.3515078482
MESH:D008106 Liver Cirrhosis, Experimental Quercetin 34.3512741479
MESH:D008106 Liver Cirrhosis, Experimental rosiglitazone 34.3517347453 15980055
MESH:D008106 Liver Cirrhosis, Experimental Sirolimus 34.3517050028
MESH:D008106 Liver Cirrhosis, Experimental Tamoxifen 34.3518564211
MESH:D008106 Liver Cirrhosis, Experimental Tetrachlorodibenzodioxin 34.3512878042
MESH:D008106 Liver Cirrhosis, Experimental Tretinoin 34.3518397230 16248980
MESH:D008107 Liver Diseases Acetaminophen 15.6912969438 12587719 19460945 16610002 16611625 11587558 19784758 19014921
MESH:D008107 Liver Diseases Carbon Tetrachloride 15.6916964402 17285989 15830285 16246199 15720792
MESH:D008107 Liver Diseases Curcumin 15.6916956363
MESH:D008107 Liver Diseases DDT 15.6915729006
MESH:D008107 Liver Diseases Diethylnitrosamine 15.6917034775
MESH:D008107 Liver Diseases Dinoprostone 15.6915816358
MESH:D008107 Liver Diseases Phenobarbital 15.6919363144
MESH:D008107 Liver Diseases Plant Extracts 15.6917034775
MESH:D017093 Liver Failure Carbon Tetrachloride 3.1815123358
MESH:D017114 Liver Failure, Acute Acetaminophen 11.0916871587 17185352
MESH:D017114 Liver Failure, Acute Carbon Tetrachloride 11.0914706259 16899240
MESH:D017114 Liver Failure, Acute Dimethylnitrosamine 11.0917457977
MESH:D008113 Liver Neoplasms 2,6-dinitrotoluene 50.717678174
MESH:D008113 Liver Neoplasms 2-Acetylaminofluorene 50.7110737359 14678523 10672840 11376686 16273603 18001218
MESH:D008113 Liver Neoplasms Aflatoxin B1 50.7115890375 2125692 18177683 9163691
MESH:D008113 Liver Neoplasms arsenic trioxide 50.7114682389
MESH:D008113 Liver Neoplasms Carbon Tetrachloride 50.7119294768
MESH:D008113 Liver Neoplasms DDT 50.7115975961 11948501
MESH:D008113 Liver Neoplasms Diethylnitrosamine 50.719163691 20434301 20405173 19294768 21047994 19850985 19256749 2422723 19073162 19090486 19642983 19551842 15885732 19812893 20583210 12771043 20118626 19690152 21167192 19254457 19499222 20452335 16942905 20101389 19833225 20137499 18978307 18648771 19638242 18977376 21278145 18754104 19427195 12112319 2862719 18644402 20492335 15175105 20501860 21071580 10737359 19255062 19426721 19996281
MESH:D008113 Liver Neoplasms Diethylstilbestrol 50.7115890375 16712894
MESH:D008113 Liver Neoplasms Dimethylnitrosamine 50.7115890375 3113478
MESH:D008113 Liver Neoplasms perfluorooctanoic acid 50.7114757943 18709148
MESH:D008113 Liver Neoplasms Phenobarbital 50.718742319 19482888 19073162 21047994 15975961 19812893
MESH:D008113 Liver Neoplasms pirinixic acid 50.7120007298 15890375 16377806
MESH:D008113 Liver Neoplasms Plant Extracts 50.7119168119
MESH:D008113 Liver Neoplasms Quercetin 50.7118980244
MESH:D008113 Liver Neoplasms resveratrol 50.7119073162 20405173 19812893 19321006
MESH:D008113 Liver Neoplasms Tamoxifen 50.7116684651
MESH:D008113 Liver Neoplasms Tetrachlorodibenzodioxin 50.7116984957
MESH:D008113 Liver Neoplasms Urethane 50.7117093202 17559639 16391232
MESH:D008114 Liver Neoplasms, Experimental 2,6-dinitrotoluene 35.502876786 2876784 6135515
MESH:D008114 Liver Neoplasms, Experimental 2-Acetylaminofluorene 35.506150874 534488 1399818
MESH:D008114 Liver Neoplasms, Experimental 4,4'-diaminodiphenylmethane 35.503712494 6587162 598648 1399818
MESH:D008114 Liver Neoplasms, Experimental Aflatoxin B1 35.508603461
MESH:D008114 Liver Neoplasms, Experimental arsenic trioxide 35.5020377131
MESH:D008114 Liver Neoplasms, Experimental Carbon Tetrachloride 35.5012014681 15583823
MESH:D008114 Liver Neoplasms, Experimental Diethylnitrosamine 35.5019519916 18544905 19004024 18079962 18253720 18775883 9362446 16267830 17174075 2563599 18282651 19539802 19126423 17854601 18308698 19009564 18164116 21159647 18093689 3124819 17942915 16842330
MESH:D008114 Liver Neoplasms, Experimental Dimethylnitrosamine 35.501848544 6150874 15603536
MESH:D008114 Liver Neoplasms, Experimental Doxorubicin 35.5016842330 17085340
MESH:D008114 Liver Neoplasms, Experimental Phenobarbital 35.501399818 6150874 17172636 18308698 2563599
MESH:D008114 Liver Neoplasms, Experimental Quercetin 35.5019519916
MESH:D008114 Liver Neoplasms, Experimental Tetrachlorodibenzodioxin 35.5012151625
MESH:D008133 Long QT Syndrome arsenic trioxide 2.5515213294
MESH:D008171 Lung Diseases Acetylcysteine 8.2912815614
MESH:D008171 Lung Diseases Mustard Gas 8.2918702808 18161513
MESH:D008171 Lung Diseases nitrofen 8.2916863852 9859898 9614859 17245593
MESH:D017563 Lung Diseases, Interstitial Valproic Acid 3.2517228818
MESH:D055370 Lung Injury Asbestos, Crocidolite 6.4617365036
MESH:D055370 Lung Injury pyrrolidine dithiocarbamic acid 6.4616129981
MESH:D008175 Lung Neoplasms 2-Acetylaminofluorene 31.1611376686
MESH:D008175 Lung Neoplasms Acetaldehyde 31.1617372256
MESH:D008175 Lung Neoplasms Aflatoxin B1 31.1614755239
MESH:D008175 Lung Neoplasms arsenic trioxide 31.1619825857 11798837
MESH:D008175 Lung Neoplasms bexarotene 31.1617849452
MESH:D008175 Lung Neoplasms Cisplatin 31.1617225452 11798837 6189445
MESH:D008175 Lung Neoplasms Curcumin 31.1619359593 18462866 16243823
MESH:D008175 Lung Neoplasms Dexamethasone 31.1615824018 11195469
MESH:D008175 Lung Neoplasms Diethylnitrosamine 31.1620512841 20970405 6695378 21163286
MESH:D008175 Lung Neoplasms Dimethylnitrosamine 31.1616061637 11884234 19555203
MESH:D008175 Lung Neoplasms Doxorubicin 31.1617418594 6189445
MESH:D008175 Lung Neoplasms Indomethacin 31.1616537180 11497255 11053908
MESH:D008175 Lung Neoplasms Mustard Gas 31.168781369 3148597
MESH:D008175 Lung Neoplasms Plant Extracts 31.1620869020
MESH:D008175 Lung Neoplasms Quercetin 31.1616280456
MESH:D008175 Lung Neoplasms Tamoxifen 31.1618625569
MESH:D008175 Lung Neoplasms Tetrachlorodibenzodioxin 31.1619555203 11884234
MESH:D008175 Lung Neoplasms Urethane 31.1611323394 14587096 11992545 10530776 6695378 11307925 17255336 17195641 10822126 15136453 12466968 11062179 15902970 7750092 16289808 11074608 16926031 17093202 12765245 10779650 11544531 16788158 11807781 16007126 16204055 16391232 11893704 11246140 15166089 12117781 12957351 11552296 16337739 10997738 11497255
MESH:D008181 Lupus Nephritis Diethylstilbestrol 4.1515166399
MESH:D008223 Lymphoma Curcumin 11.5318462866
MESH:D008223 Lymphoma Diethylstilbestrol 11.5315700306
MESH:D008223 Lymphoma Doxorubicin 11.5316098063
MESH:D008223 Lymphoma Etoposide 11.5312854902 12556972
MESH:D016393 Lymphoma, B-Cell resveratrol 7.1717088997
MESH:D016393 Lymphoma, B-Cell Sodium Selenite 7.1714737004
MESH:D008228 Lymphoma, Non-Hodgkin Doxorubicin 6.0417654614
MESH:D008228 Lymphoma, Non-Hodgkin resveratrol 6.0414749477
MESH:D016399 Lymphoma, T-Cell Curcumin 8.3116173963
MESH:D016399 Lymphoma, T-Cell Doxorubicin 8.3115621674
MESH:D016410 Lymphoma, T-Cell, Cutaneous bexarotene 4.1611161223
MESH:D052801 Male Urogenital Diseases Diethylstilbestrol 4.4916002989
MESH:D015674 Mammary Neoplasms, Animal resveratrol 6.7115688416
MESH:D015674 Mammary Neoplasms, Animal Tamoxifen 6.7119428831
MESH:D008325 Mammary Neoplasms, Experimental bexarotene 35.5819196723 15591091 19196722
MESH:D008325 Mammary Neoplasms, Experimental Doxorubicin 35.5815458769
MESH:D008325 Mammary Neoplasms, Experimental Estradiol 35.5817203775 11807958 11408345 16891317
MESH:D008325 Mammary Neoplasms, Experimental gefitinib 35.5818375820
MESH:D008325 Mammary Neoplasms, Experimental Genistein 35.5814578162 12929590
MESH:D008325 Mammary Neoplasms, Experimental Ibuprofen 35.5810697514
MESH:D008325 Mammary Neoplasms, Experimental Progesterone 35.5811408345 17203775
MESH:D008325 Mammary Neoplasms, Experimental resveratrol 35.588985016 11606380
MESH:D008325 Mammary Neoplasms, Experimental rosiglitazone 35.5816827153
MESH:D008325 Mammary Neoplasms, Experimental Selenium 35.5815318939
MESH:D008325 Mammary Neoplasms, Experimental Tamoxifen 35.5816827153 14580682 19196723 19196722 11731420
MESH:D008325 Mammary Neoplasms, Experimental Zinc 35.5812773700
MESH:D020149 Manganese Poisoning Estradiol 9.2719453300
MESH:D020149 Manganese Poisoning Tamoxifen 9.2719453300
MESH:D008527 Medulloblastoma Tretinoin 2.2617453147
MESH:D008545 Melanoma 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline 15.1716077934
MESH:D008545 Melanoma Cisplatin 15.1712393984 16248763 11135225 17023156 18176117 18505091 18332650 17761969 12374674 16432458 12883367 16809738 15577323
MESH:D008545 Melanoma Curcumin 15.1718462866 17885582
MESH:D008545 Melanoma Doxorubicin 15.1716827129
MESH:D008545 Melanoma epigallocatechin gallate 15.1711746506 17992120
MESH:D008545 Melanoma resveratrol 15.1717992120
MESH:D008545 Melanoma Sirolimus 15.1719282848
MESH:D008545 Melanoma Tamoxifen 15.1712393984 19393235
MESH:D008545 Melanoma Tretinoin 15.1716752155
MESH:D018328 Melanoma, Amelanotic Cisplatin 8.2015990972
MESH:D018328 Melanoma, Amelanotic Tamoxifen 8.2015990972
MESH:D008546 Melanoma, Experimental Acetaminophen 2.5919513568
MESH:D008569 Memory Disorders Curcumin 3.2117263510
MESH:D008591 Meningomyelocele Tretinoin 3.4416940565
MESH:D008654 Mesothelioma Asbestos, Crocidolite 10.0618303189 16966607 16166281
MESH:D008654 Mesothelioma Cisplatin 10.0617638057
MESH:D008654 Mesothelioma Doxorubicin 10.0617638057
MESH:D008654 Mesothelioma Selenium 10.0615107826
MESH:D008659 Metabolic Diseases resveratrol 3.4617112576
MESH:D024821 Metabolic Syndrome X Fructose 7.1816815490 18497449 19165636 17261469 17098227
MESH:D024821 Metabolic Syndrome X rosiglitazone 7.1817261469
MESH:D008664 Metal Metabolism, Inborn Errors Cyclosporine 3.7716801185
MESH:D008881 Migraine Disorders Indomethacin 5.1311903285
MESH:D008881 Migraine Disorders Valproic Acid 5.1318803445 18765137
MESH:D020326 Migraine without Aura Dinoprostone 4.3111304026
MESH:D028361 Mitochondrial Diseases Doxorubicin 3.5815792986
MESH:D009062 Mouth Neoplasms Indomethacin 6.4912636206
MESH:D009062 Mouth Neoplasms Sirolimus 6.4919435901
MESH:D052016 Mucositis Doxorubicin 3.7917415656
MESH:D009101 Multiple Myeloma arsenic trioxide 10.9114977855 19417148 11468182 19549372 15949261
MESH:D009101 Multiple Myeloma Curcumin 10.9119372569
MESH:D009101 Multiple Myeloma Dexamethasone 10.9115867202 15744524 16118317
MESH:D009101 Multiple Myeloma resveratrol 10.9114749477 17049120 16267019 17935668 17164350 16490592
MESH:D009134 Muscular Atrophy, Spinal Curcumin 15.4017962980
MESH:D009134 Muscular Atrophy, Spinal epigallocatechin gallate 15.4017962980
MESH:D009134 Muscular Atrophy, Spinal resveratrol 15.4017962980
MESH:D009135 Muscular Diseases pirinixic acid 2.5316239165
MESH:D009137 Muscular Dystrophy, Animal Gentamicins 5.2518694830
MESH:D009139 Musculoskeletal Abnormalities Valproic Acid 3.118888407
MESH:D009182 Mycosis Fungoides arsenic trioxide 3.6518349030
MESH:D009190 Myelodysplastic Syndromes arsenic trioxide 11.9516105982 16882451
MESH:D009190 Myelodysplastic Syndromes Dexamethasone 11.959809623
MESH:D009190 Myelodysplastic Syndromes Tretinoin 11.9517596541
MESH:D009190 Myelodysplastic Syndromes Valproic Acid 11.9517596541
MESH:D009203 Myocardial Infarction Doxorubicin 11.9415857846 19429709
MESH:D009203 Myocardial Infarction Genistein 11.9417141266
MESH:D009203 Myocardial Infarction pirinixic acid 11.9419151258
MESH:D009203 Myocardial Infarction Quercetin 11.9419595682
MESH:D009203 Myocardial Infarction resveratrol 11.9416456233 16525036 16317513 17188708 17015251 17125593
MESH:D017202 Myocardial Ischemia resveratrol 6.2117125593 17015251
MESH:D017202 Myocardial Ischemia Tetrachlorodibenzodioxin 6.2112213967
MESH:D015428 Myocardial Reperfusion Injury Estradiol 17.9916810080
MESH:D015428 Myocardial Reperfusion Injury Genistein 17.9917141266
MESH:D015428 Myocardial Reperfusion Injury Norepinephrine 17.9915642760
MESH:D015428 Myocardial Reperfusion Injury pirinixic acid 17.9916411023
MESH:D015428 Myocardial Reperfusion Injury Quercetin 17.9919207477
MESH:D009205 Myocarditis resveratrol 3.7617322642
MESH:D020191 Myoclonic Epilepsies, Progressive Phenobarbital 3.4717484760
MESH:D009336 Necrosis 2,4-dinitrotoluene 7.0518551238
MESH:D009336 Necrosis 2,6-dinitrotoluene 7.0518551238 7678174
MESH:D009361 Neoplasm Invasiveness arsenic trioxide 7.1516624393
MESH:D009361 Neoplasm Invasiveness Curcumin 7.1518495463
MESH:D009362 Neoplasm Metastasis 4,4'-diaminodiphenylmethane 15.393581430
MESH:D009362 Neoplasm Metastasis Acetylcysteine 15.3914720322
MESH:D009362 Neoplasm Metastasis Diethylnitrosamine 15.399029167 3581430
MESH:D009362 Neoplasm Metastasis Doxorubicin 15.3918259882
MESH:D009362 Neoplasm Metastasis Indomethacin 15.3911239499 11053908 16537180
MESH:D009362 Neoplasm Metastasis Tamoxifen 15.3919393235
MESH:D009364 Neoplasm Recurrence, Local Tamoxifen 2.0719410462
MESH:D009369 Neoplasms Cisplatin 14.5716773208
MESH:D009369 Neoplasms DDT 14.578820588
MESH:D009369 Neoplasms Diethylstilbestrol 14.5715313581
MESH:D009369 Neoplasms pirinixic acid 14.5717405874
MESH:D009369 Neoplasms Quercetin 14.5715185748
MESH:D009369 Neoplasms Tretinoin 14.5716946489 16594593
MESH:D009369 Neoplasms Urethane 14.5715625555
MESH:D009374 Neoplasms, Experimental Indomethacin 9.9110663608 15625704
MESH:D009374 Neoplasms, Experimental resveratrol 9.918985016
MESH:D009374 Neoplasms, Experimental Urethane 9.9115582191
MESH:D009376 Neoplasms, Hormone-Dependent bexarotene 17.9419196722
MESH:D009376 Neoplasms, Hormone-Dependent Curcumin 17.9412497104
MESH:D009376 Neoplasms, Hormone-Dependent Nevirapine 17.9419152342
MESH:D009376 Neoplasms, Hormone-Dependent Tamoxifen 17.9419196722 19200415 19189210
MESH:D009389 Neovascularization, Pathologic Estradiol 2.7517289903
MESH:D009395 Nephritis, Interstitial Cisplatin 7.5615464296
MESH:D009395 Nephritis, Interstitial Ibuprofen 7.566375363
MESH:D009401 Nephrosis Doxorubicin 3.7916899518 16636307
MESH:D009402 Nephrosis, Lipoid Cyclosporine 3.4217954296
MESH:D009404 Nephrotic Syndrome Cyclosporine 6.3819348381 18481113
MESH:D009404 Nephrotic Syndrome Doxorubicin 6.3815640375 16889571
MESH:D009410 Nerve Degeneration Ibuprofen 3.5810961664
MESH:D009421 Nervous System Malformations Diethylstilbestrol 20.7411399458
MESH:D009421 Nervous System Malformations Estradiol 20.7411399458 16427766
MESH:D009421 Nervous System Malformations Genistein 20.7416427766
MESH:D009421 Nervous System Malformations Tetrachlorodibenzodioxin 20.7414600291
MESH:D009421 Nervous System Malformations Tretinoin 20.749125849
MESH:D009423 Nervous System Neoplasms Curcumin 4.6118462866
MESH:D009436 Neural Tube Defects 4,4'-diaminodiphenylmethane 14.956679447
MESH:D009436 Neural Tube Defects Acetylcysteine 14.9519446573
MESH:D009436 Neural Tube Defects arsenic trioxide 14.9510525206
MESH:D009436 Neural Tube Defects Tretinoin 14.959142499
MESH:D009436 Neural Tube Defects Valproic Acid 14.9516359493 8888407
MESH:D019954 Neurobehavioral Manifestations Plant Extracts 4.2017168769
MESH:D009447 Neuroblastoma Cisplatin 5.018761367
MESH:D009447 Neuroblastoma Doxorubicin 5.0115555623
MESH:D019636 Neurodegenerative Diseases Acetaminophen 13.1318514411
MESH:D019636 Neurodegenerative Diseases Diethylnitrosamine 13.1320387270
MESH:D019636 Neurodegenerative Diseases Indomethacin 13.1312349958
MESH:D019636 Neurodegenerative Diseases resveratrol 13.1317652729
MESH:D017599 Neuroectodermal Tumors Cisplatin 3.708761367
MESH:D020078 Neurogenic Inflammation Quercetin 7.5817929310
MESH:D020078 Neurogenic Inflammation resveratrol 7.5817929310
MESH:D009461 Neurologic Manifestations Diethylnitrosamine 4.1020387270
MESH:D009503 Neutropenia Mustard Gas 3.057688884 16761898
MESH:D052556 Niemann-Pick Disease, Type C perfluorooctanoic acid 3.979802331
MESH:D009765 Obesity Curcumin 7.4119297423
MESH:D009765 Obesity Fructose 7.4118585860 17707055
MESH:D009765 Obesity pirinixic acid 7.4120558911
MESH:D009765 Obesity Plant Extracts 7.4119056576 20132043
MESH:D007752 Obstetric Labor, Premature Indomethacin 4.156374098
MESH:D009784 Occupational Diseases 2,4-dinitrotoluene 9.9112819281 16049721
MESH:D009784 Occupational Diseases 2,6-dinitrotoluene 9.9116049721
MESH:D009784 Occupational Diseases 4,4'-diaminodiphenylmethane 9.914026338 6482804
MESH:D009902 Optic Neuritis 4,4'-diaminodiphenylmethane 4.003988306
MESH:D010003 Osteoarthritis Ibuprofen 5.697009135
MESH:D010003 Osteoarthritis Indomethacin 5.697009135
MESH:D010005 Osteoarthropathy, Secondary Hypertrophic Dinoprostone 5.4518500342
MESH:D010018 Osteomalacia Phenobarbital 3.3717016548
MESH:D010024 Osteoporosis Calcium 7.8617882678
MESH:D010024 Osteoporosis Curcumin 7.8618719352
MESH:D010024 Osteoporosis Genistein 7.8619401787
MESH:D015663 Osteoporosis, Postmenopausal Genistein 11.5116169203
MESH:D015663 Osteoporosis, Postmenopausal Quercetin 11.5119495926
MESH:D015663 Osteoporosis, Postmenopausal resveratrol 11.5117513867
MESH:D012516 Osteosarcoma Doxorubicin 3.2715930896
MESH:D010051 Ovarian Neoplasms 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 40.0816211241
MESH:D010051 Ovarian Neoplasms 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline 40.0816211241
MESH:D010051 Ovarian Neoplasms arsenic trioxide 40.0816624393 19769630 12452020
MESH:D010051 Ovarian Neoplasms Cisplatin 40.0817225452 15464296 6897625 19769630
MESH:D010051 Ovarian Neoplasms Curcumin 40.0818462866 19020741
MESH:D010051 Ovarian Neoplasms Estradiol 40.0819401270
MESH:D010051 Ovarian Neoplasms Genistein 40.0819005980
MESH:D010051 Ovarian Neoplasms Luteolin 40.0819005980
MESH:D010051 Ovarian Neoplasms Mifepristone 40.0816525653
MESH:D010051 Ovarian Neoplasms Progesterone 40.0816525653 17393432
MESH:D010051 Ovarian Neoplasms Quercetin 40.0819005980
MESH:D010051 Ovarian Neoplasms Tretinoin 40.0816936753
MESH:D010051 Ovarian Neoplasms U 0126 40.0816211241
MESH:D010051 Ovarian Neoplasms Urethane 40.0816391232
MESH:D010146 Pain Acetaminophen 9.3016870215
MESH:D010146 Pain Ibuprofen 9.303291741
MESH:D010146 Pain Indomethacin 9.3017627676 17440234 3291741 13679232
MESH:D010146 Pain Tretinoin 9.3016870215
MESH:D010149 Pain, Postoperative Ibuprofen 8.1216678543
MESH:D010149 Pain, Postoperative Indomethacin 8.1218702446 12538197
MESH:D010190 Pancreatic Neoplasms arsenic trioxide 23.8315580305
MESH:D010190 Pancreatic Neoplasms Cisplatin 23.8319003803
MESH:D010190 Pancreatic Neoplasms Curcumin 23.8319401701 19196508 17440100
MESH:D010190 Pancreatic Neoplasms Diethylnitrosamine 23.8316540662
MESH:D010190 Pancreatic Neoplasms Etoposide 23.8319003803
MESH:D010190 Pancreatic Neoplasms Ibuprofen 23.8312384795
MESH:D010190 Pancreatic Neoplasms Phenobarbital 23.8316965848
MESH:D010190 Pancreatic Neoplasms Quercetin 23.8316965848
MESH:D010190 Pancreatic Neoplasms Tretinoin 23.8315976015
MESH:D010195 Pancreatitis Indomethacin 3.0215028970 17883296
MESH:D010212 Papilloma 4,4'-diaminodiphenylmethane 10.067296757
MESH:D010212 Papilloma Hydrogen Peroxide 10.0612065085
MESH:D010212 Papilloma Plant Extracts 10.0616517061 15173996
MESH:D010235 Paraganglioma arsenic trioxide 3.2219927285
MESH:D010257 Paraneoplastic Syndromes Indomethacin 4.7016537180
MESH:D010300 Parkinson Disease Sirolimus 3.2819682553
MESH:D020734 Parkinsonian Disorders Indomethacin 3.2312349958
MESH:D051302 Paroxysmal Hemicrania Indomethacin 4.7011903285
MESH:D010382 Peliosis Hepatis Tetrachlorodibenzodioxin 3.2312520081
MESH:D010437 Peptic Ulcer Indomethacin 4.1511148446
MESH:D010518 Periodontitis Indomethacin 3.9017225004
MESH:D010523 Peripheral Nervous System Diseases Cisplatin 3.3615464296
MESH:D010787 Photosensitivity Disorders 4,4'-diaminodiphenylmethane 3.456228378
MESH:D003557 Phyllodes Tumor Doxorubicin 4.1417983394
MESH:D010900 Pituitary Diseases Diethylstilbestrol 4.1514722030
MESH:D010911 Pituitary Neoplasms Diethylstilbestrol 8.8815687265 16977796
MESH:D010911 Pituitary Neoplasms Urethane 8.8816391232
MESH:D010954 Plasmacytoma Selenium 3.8715087411
MESH:D010995 Pleural Diseases Asbestos, Crocidolite 3.9110923243
MESH:D010997 Pleural Neoplasms Cisplatin 10.5617638057
MESH:D010997 Pleural Neoplasms Doxorubicin 10.5617638057
MESH:D011041 Poisoning Mustard Gas 2.8915727166
MESH:D017119 Porphyria Cutanea Tarda Tetrachlorodibenzodioxin 2.6018163543
MESH:D011230 Precancerous Conditions Cyclosporine 14.7412371664
MESH:D011230 Precancerous Conditions Diethylnitrosamine 14.742563599
MESH:D011230 Precancerous Conditions Phenobarbital 14.742563599
MESH:D011230 Precancerous Conditions Quercetin 14.7419056647
MESH:D054198 Precursor Cell Lymphoblastic Leukemia-Lymphoma Dexamethasone 2.8821297632
MESH:D011225 Pre-Eclampsia Zinc 3.3517114810
MESH:D047928 Premature Birth Indomethacin 4.1417000239
MESH:D011297 Prenatal Exposure Delayed Effects Diethylstilbestrol 20.0717184923
MESH:D011297 Prenatal Exposure Delayed Effects perfluorooctanoic acid 20.0717132714
MESH:D011297 Prenatal Exposure Delayed Effects resveratrol 20.0716679765
MESH:D011297 Prenatal Exposure Delayed Effects Tetrachlorodibenzodioxin 20.0711118676 11222880 11896295 11399792
MESH:D011297 Prenatal Exposure Delayed Effects Valproic Acid 20.0720603192
MESH:D011470 Prostatic Hyperplasia Calcitriol 3.7815572423
MESH:D019048 Prostatic Intraepithelial Neoplasia Estradiol 7.8120887781
MESH:D019048 Prostatic Intraepithelial Neoplasia Testosterone 7.8120887781
MESH:D011471 Prostatic Neoplasms marker/mechanism 16340751
MESH:D011471 Prostatic Neoplasms arsenic trioxide 12.9919131511
MESH:D011471 Prostatic Neoplasms bicalutamide 12.9919240160 15638997 17914592 19011039 18487222
MESH:D011471 Prostatic Neoplasms Calcitriol 12.9912479363 16289102 15754350 18247401 16644109
MESH:D011471 Prostatic Neoplasms Curcumin 12.9911398177 18226269 18156803 18769126 12497104 15129424 10851300
MESH:D011471 Prostatic Neoplasms DDT 12.9912584743
MESH:D011471 Prostatic Neoplasms Diethylstilbestrol 12.9915046698 17136230 15846301
MESH:D011471 Prostatic Neoplasms Doxorubicin 12.9916888761 15897917 16868541 16729912 15749863 18437689
MESH:D011471 Prostatic Neoplasms Estradiol 12.9916740699
MESH:D011471 Prostatic Neoplasms Etoposide 12.9917172428
MESH:D011471 Prostatic Neoplasms Flurbiprofen 12.9917409433
MESH:D011471 Prostatic Neoplasms gefitinib 12.9916685379 15651060 17914592
MESH:D011471 Prostatic Neoplasms Genistein 12.9915378649 16925846 15256057
MESH:D011471 Prostatic Neoplasms Ibuprofen 12.9917409433
MESH:D011471 Prostatic Neoplasms Monensin 12.9919789329
MESH:D011471 Prostatic Neoplasms Nevirapine 12.9919152342
MESH:D011471 Prostatic Neoplasms Plant Extracts 12.9914666653 17804756
MESH:D011471 Prostatic Neoplasms pyrrolidine dithiocarbamic acid 12.9916139439
MESH:D011471 Prostatic Neoplasms Quercetin 12.9917292933 14715546
MESH:D011471 Prostatic Neoplasms resveratrol 12.9915767336 16731767 17636462 17718901 17804756 17675339
MESH:D011471 Prostatic Neoplasms Sodium Selenite 12.9918760546
MESH:D011471 Prostatic Neoplasms Tamoxifen 12.9915067354
MESH:D011471 Prostatic Neoplasms Zinc 12.9916606632 16517595 16700911 12429649
MESH:D011507 Proteinuria Gentamicins 14.4915033597
MESH:D011507 Proteinuria Ibuprofen 14.496375363
MESH:D011507 Proteinuria Indomethacin 14.4911849393
MESH:D011507 Proteinuria Tretinoin 14.4916636307
MESH:D011537 Pruritus Mustard Gas 3.1118058305
MESH:D019310 Pseudolymphoma Phenobarbital 8.8212752131
MESH:D019310 Pseudolymphoma Valproic Acid 8.8212752131 11422049
MESH:D011565 Psoriasis Cyclosporine 1.7616882103
MESH:D011625 Pterygium Tretinoin 3.7916723453
MESH:D011656 Pulmonary Emphysema Curcumin 3.6219168576
MESH:D011658 Pulmonary Fibrosis marker/mechanism 17266442
MESH:D011658 Pulmonary Fibrosis Asbestos, Crocidolite 6.4217365031 15814490 17975199 17322281
MESH:D011658 Pulmonary Fibrosis gefitinib 6.4218424623
MESH:D011658 Pulmonary Fibrosis Mustard Gas 6.4217266442 17894541 10334151 17620002 17720292
MESH:D051437 Renal Insufficiency Cisplatin 11.6815464296
MESH:D051437 Renal Insufficiency Doxorubicin 11.6817922066
MESH:D051437 Renal Insufficiency Gentamicins 11.6817132701 15728788
MESH:D051436 Renal Insufficiency, Chronic resveratrol 4.5616325855
MESH:D015427 Reperfusion Injury marker/mechanism 16526316
MESH:D015427 Reperfusion Injury pirinixic acid 4.5119058328
MESH:D015427 Reperfusion Injury resveratrol 4.5117520802 16314181 16317513 15827377 17058453
MESH:D012128 Respiratory Distress Syndrome, Adult Acetylcysteine 14.1012210543
MESH:D012128 Respiratory Distress Syndrome, Adult Curcumin 14.1018379247 10666014
MESH:D012128 Respiratory Distress Syndrome, Adult Dexamethasone 14.1011700416 18379247
MESH:D012128 Respiratory Distress Syndrome, Adult pyrrolidine dithiocarbamic acid 14.1016129981
MESH:D015619 Respiratory System Abnormalities Tetrachlorodibenzodioxin 2.8718990726
MESH:D012162 Retinal Degeneration 4,4'-diaminodiphenylmethane 6.313692021
MESH:D012162 Retinal Degeneration Zinc 6.3116584753
MESH:D012173 Retinitis Gentamicins 5.2518644591
MESH:D012208 Rhabdomyosarcoma Tretinoin 7.7516283617 16116481
MESH:D012208 Rhabdomyosarcoma Valproic Acid 7.7519155313
MESH:D012220 Rhinitis Acetaldehyde 3.8717050345
MESH:D012468 Salivary Gland Neoplasms Progesterone 2.3818045962
MESH:D012509 Sarcoma Curcumin 6.6018462866
MESH:D012509 Sarcoma Doxorubicin 6.6015625365 15675481 17710206 18313854 16767912 17203757
MESH:D012512 Sarcoma, Ewing's arsenic trioxide 22.2416646077
MESH:D012512 Sarcoma, Ewing's Cisplatin 22.2414601052
MESH:D012512 Sarcoma, Ewing's Dactinomycin 22.2414601052
MESH:D012512 Sarcoma, Ewing's Doxorubicin 22.2416326096 14601052
MESH:D012512 Sarcoma, Ewing's Etoposide 22.2414601052
MESH:D012514 Sarcoma, Kaposi Doxorubicin 3.7917846226
MESH:D012554 Schistosomiasis japonica Quercetin 4.5216862918
MESH:D012559 Schizophrenia Valproic Acid 1.9019110320 15737665
MESH:D012640 Seizures 2,4-dinitrotoluene 7.9418551238
MESH:D012640 Seizures 2,6-dinitrotoluene 7.9418551238
MESH:D012640 Seizures Phenobarbital 7.943137016 16876388 4039156 11442880
MESH:D012640 Seizures Valproic Acid 7.9411044598 16876388 14763951 17978042 1511512 11738929 3137016 15475178
MESH:D003294 Seizures, Febrile Phenobarbital 3.826407741
MESH:D018805 Sepsis Curcumin 3.2218389075
MESH:D012735 Sexual Dysfunction, Physiological Testosterone 5.1816631401
MESH:D012852 Sinusitis Phenylephrine 3.717327846
MESH:D012871 Skin Diseases Mustard Gas 2.3612880345 15451306 16961503
MESH:D012878 Skin Neoplasms Doxorubicin 17.9715692506
MESH:D012878 Skin Neoplasms Hydrogen Peroxide 17.9712065085
MESH:D012878 Skin Neoplasms Plant Extracts 17.9715173996 16517061
MESH:D012878 Skin Neoplasms resveratrol 17.9715837718 8985016
MESH:D012878 Skin Neoplasms Tetrachlorodibenzodioxin 17.9716192470
MESH:D012878 Skin Neoplasms Tretinoin 17.9716467112
MESH:D012878 Skin Neoplasms Urethane 17.9711807781
MESH:D055752 Small Cell Lung Carcinoma Cisplatin 4.3215464296
MESH:D012983 Soft Tissue Neoplasms Doxorubicin 3.5917203757 16767912 15625365
MESH:D013088 Spermatocele Diethylstilbestrol 8.4816002989 16709447
MESH:D013088 Spermatocele Tamoxifen 8.4816709447
MESH:D013119 Spinal Cord Injuries Progesterone 7.5716503802 15862959
MESH:D013119 Spinal Cord Injuries Tamoxifen 7.5719457130
MESH:D016135 Spinal Dysraphism Valproic Acid 2.9519490988
MESH:D013158 Splenic Diseases Dimethylnitrosamine 4.2512587719
MESH:D013226 Status Epilepticus Valproic Acid 3.5212833885
MESH:D013272 Stomach Diseases Dexamethasone 11.4315472012
MESH:D013272 Stomach Diseases Indomethacin 11.4318545984 15038085 10192188 10486359 17638125 15472012 16280098 16113693 18209964 10215738 16184426 17207306 17160473
MESH:D013272 Stomach Diseases Omeprazole 11.4318545984
MESH:D013274 Stomach Neoplasms arsenic trioxide 5.7117007042
MESH:D013274 Stomach Neoplasms Cisplatin 5.7118396642 17522103 15958060
MESH:D013274 Stomach Neoplasms Diethylnitrosamine 5.7118456281
MESH:D013274 Stomach Neoplasms Dimethylnitrosamine 5.7116033868
MESH:D013274 Stomach Neoplasms Indomethacin 5.7115609394
MESH:D013274 Stomach Neoplasms Tretinoin 5.7117261132
MESH:D013276 Stomach Ulcer Acetylcysteine 24.0517918041
MESH:D013276 Stomach Ulcer allylpyrocatechol 24.0518431645
MESH:D013276 Stomach Ulcer Aluminum Silicates 24.0516335828
MESH:D013276 Stomach Ulcer Curcumin 24.0519188055 16631530
MESH:D013276 Stomach Ulcer Dexamethasone 24.0515138204
MESH:D013276 Stomach Ulcer Indomethacin 24.0512077510 12787963 1323529 11595415 15104355 12467913 11906479 12498302 17627676 14567935 18431645 18726076 16631530 17657623 17977527 17135157 16150113 10750652 16755016 11595431 17918041 12500499 16397915 11145282 15138204 11729361 16934674 16169175 18181030 18237397 10423059 17654042 10878458 18299717 17895592 16252198 18087811 15255614 18543354 18193104 18209962 11523592
MESH:D013276 Stomach Ulcer Omeprazole 24.0517977527 10750652 11906479 15991576 18237397 16755016
MESH:D013276 Stomach Ulcer Plant Extracts 24.0518237397 17135157 18193104 15255614 12787963
OMIM:601367 STROKE, ISCHEMIC resveratrol 3.5816321402
MESH:D013576 Syndactyly methoxyacetic acid 4.671761407 1761404
MESH:D013610 Tachycardia Norepinephrine 4.483261545
MESH:D013705 Temporomandibular Joint Disorders Plant Extracts 4.4617997062
MESH:D013733 Testicular Diseases methoxyacetic acid 4.346499806 18486176
MESH:D013736 Testicular Neoplasms Cisplatin 3.6915464296 17225452
MESH:D013959 Thyroid Diseases Tetrachlorodibenzodioxin 2.8912697716
MESH:D013964 Thyroid Neoplasms 4,4'-diaminodiphenylmethane 29.663712494 6582329 6587162 1399818 7505956
MESH:D013964 Thyroid Neoplasms 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine 29.6616940797
MESH:D013964 Thyroid Neoplasms arsenic trioxide 29.6619014326
MESH:D013964 Thyroid Neoplasms Diethylnitrosamine 29.667505956
MESH:D013964 Thyroid Neoplasms Doxorubicin 29.6617909728 16010429
MESH:D013964 Thyroid Neoplasms gefitinib 29.6616940797
MESH:D013964 Thyroid Neoplasms Indomethacin 29.6618791128 14736730 11352223
MESH:D013964 Thyroid Neoplasms Phenobarbital 29.661399818
MESH:D013964 Thyroid Neoplasms Tretinoin 29.6616026305 17045167
MESH:D013978 Tibial Fractures Estradiol 3.6719048282
MESH:D014062 Tongue Neoplasms resveratrol 11.4616227395
MESH:D014062 Tongue Neoplasms Tretinoin 11.4616051514
MESH:D014062 Tongue Neoplasms Zinc 11.4616543248
MESH:D016171 Torsades de Pointes arsenic trioxide 2.9715213294
MESH:D014178 Translocation, Genetic Valproic Acid 4.2117262798
MESH:D014376 Tuberculosis Tretinoin 2.5116040207
MESH:D014402 Tuberous Sclerosis Sirolimus 4.6121115397 18495876
MESH:D014456 Ulcer Indomethacin 3.8917380554 10574470
MESH:D020194 Unverricht-Lundborg Syndrome Valproic Acid 3.523119515
MESH:D001749 Urinary Bladder Neoplasms 2,4-dinitrotoluene 29.2316049721
MESH:D001749 Urinary Bladder Neoplasms 2,6-dinitrotoluene 29.2316049721
MESH:D001749 Urinary Bladder Neoplasms 2-Acetylaminofluorene 29.231399818 15867355 15289314
MESH:D001749 Urinary Bladder Neoplasms 4,4'-diaminodiphenylmethane 29.238074119
MESH:D001749 Urinary Bladder Neoplasms arsenic trioxide 29.2312845720 20435036 12973940 11780464
MESH:D001749 Urinary Bladder Neoplasms Cisplatin 29.2315464296 17225452 12973940
MESH:D001749 Urinary Bladder Neoplasms Curcumin 29.2318593936
MESH:D001749 Urinary Bladder Neoplasms Diethylstilbestrol 29.2317306315 16712894 16452187
MESH:D001749 Urinary Bladder Neoplasms Doxorubicin 29.2317653716
MESH:D001749 Urinary Bladder Neoplasms Quercetin 29.2316720314
MESH:D001749 Urinary Bladder Neoplasms Tamoxifen 29.2317572228 16712894 8653321
MESH:D014564 Urogenital Abnormalities Valproic Acid 3.668888407
MESH:D014565 Urogenital Neoplasms Curcumin 4.2618462866
MESH:D014570 Urologic Diseases DDT 4.6216487989
MESH:D014571 Urologic Neoplasms 2,4-dinitrotoluene 8.6710091137
MESH:D014571 Urologic Neoplasms 2,6-dinitrotoluene 8.6710091137
MESH:D014581 Urticaria Acetaminophen 2.0610982225
MESH:D002583 Uterine Cervical Neoplasms Cisplatin 15.3616803524
MESH:D002583 Uterine Cervical Neoplasms Diethylstilbestrol 15.3616175088
MESH:D002583 Uterine Cervical Neoplasms resveratrol 15.3617473185
MESH:D002583 Uterine Cervical Neoplasms Tretinoin 15.3616129372
MESH:D014591 Uterine Diseases Diethylstilbestrol 4.1514652134
MESH:D014594 Uterine Neoplasms Diethylstilbestrol 6.6216690809 15809267
MESH:D014594 Uterine Neoplasms resveratrol 6.6217044934
MESH:D014604 Uveal Neoplasms Tretinoin 3.5916752155
MESH:D014605 Uveitis Cyclosporine 14.491336536
MESH:D014605 Uveitis Dexamethasone 14.491336536
MESH:D014605 Uveitis Sirolimus 14.491336536
MESH:D014625 Vaginal Neoplasms Cisplatin 7.8415577323
MESH:D014625 Vaginal Neoplasms Diethylstilbestrol 7.8416002989 16513791
MESH:D054079 Vascular Malformations Tetrachlorodibenzodioxin 3.5712125929
MESH:D019043 Vascular Neoplasms Urethane 4.8910620525
MESH:D020301 Vasospasm, Intracranial Ibuprofen 4.1919057314
MESH:D018487 Ventricular Dysfunction, Left Doxorubicin 11.6317678736 16364871 17334414 17638931
MESH:D018487 Ventricular Dysfunction, Left Plant Extracts 11.6318097624
MESH:D018487 Ventricular Dysfunction, Left resveratrol 11.6317488730
MESH:D020257 Ventricular Remodeling Plant Extracts 4.3118097624
MESH:D015837 Vestibular Diseases Gentamicins 4.5618776599
MESH:D014820 Vitiligo Tretinoin 3.1016761959
MESH:D014839 Vomiting Cisplatin 8.1711897121
MESH:D014839 Vomiting Indomethacin 8.1711897121
MESH:D019282 Wasting Syndrome Tetrachlorodibenzodioxin 3.2315886252
MESH:D009396 Wilms Tumor Tretinoin 3.0816287080
MESH:D014947 Wounds and Injuries Plant Extracts 3.4120213670 19894650
MESH:D014985 Xerophthalmia Cyclosporine 3.4217120751
Pathway ID Pathway Name
KEGG:05219 Bladder cancer
KEGG:04060 Cytokine-cytokine receptor interaction
KEGG:04144 Endocytosis
KEGG:05213 Endometrial cancer
KEGG:04012 ErbB signaling pathway
KEGG:04510 Focal adhesion
KEGG:04540 Gap junction
KEGG:05214 Glioma
REACT:604 Hemostasis
KEGG:05160 Hepatitis C
KEGG:04010 MAPK signaling pathway
KEGG:05218 Melanoma
KEGG:05223 Non-small cell lung cancer
KEGG:05212 Pancreatic cancer
KEGG:05200 Pathways in cancer
KEGG:05215 Prostate cancer
KEGG:04810 Regulation of actin cytoskeleton
REACT:9417 Signaling by EGFR
Pharmacogenomics Knowledge Base Top
  • PharmGKB Accession:PA27664
    • No data
    Releated disease ID Related disease Name
    PA443622Carcinoma, Non-Small-Cell Lung
    PA445062Neoplasms
    PA444818Lung Neoplasms
    Releated drug ID Related drug Name
    PA449383docetaxel
    PA10040cetuximab
    PA131301952gefitinib
    PA449780glutathione
    PA448478l-arginine
    PA450635nitric oxide
    PA448948chloroquine
    Drug Bank Top
    Drugbank ID Action Drug Name Description
    DB00364 agonist Sucralfate Anti-Ulcer Agents
    DB04454 - Alpha-Aminobutyric Acid
    No data
    No data
    No data

    Simple Query:


      (e.g. CHD8)

    Syndromic Genes

    Non-syndromic Genes

    AutismKB Statistics

    • Studies: 1,036
    • Genes: 1,379
    • CNVs/SVs: 5,420
    • SNVs/Indels: 11,669
    • de novo Mutations: 5,669
    • Mosaics: 789
    • Linkage Regions: 172
    • Paper Collected: 6/30/2018
    • Last Update: 8/26/2018


    Copyright © 2017, Center for Bioinformatics , Peking University | All Rights Reserved